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Meningitis in newborns is a serious infection that causes mortality and neurological injury 
worldwide. The infection progresses from sepsis, and is dependent on the pathogen being able 
to cross the blood-brain barrier and invade the spinal fluid. One of the most common gram-
negative organisms to cause neonatal meningitis is Escherichia coli. In this work, neonatal 
meningitis-causing E. coli strains H622 and IHE3034 were grown in clinical blood cultures 
alongside commensal E. coli K12 derivative J53. The bacteria were purified, lysed, and digested 
with proteases, before being analysed using mass spectrometry. The mass spectrometry results 
were quantified in order to create quantitative protein profiles of each bacterium. By using 
statistical and computational analysis, we compared the strains and identified proteins that were 
differentially expressed between the pathogenic strains and J53. The results indicate that the 
pathogenic strains share a number of regulatory mechanism, and demonstrate a higher 
expression than J53 of virulence factors, motility proteins, and proteins involved in capsule 
synthesis. In addition to the mass spectrometric analysis, the bacteria were characterised using 
genetic and phenotypic methods. The results indicate that the pathogenic strains H622 and 
IHE3034 share a closer evolutionary relationship than either does with J53.  
The mass spectrometry raw files have been deposited to the ProteomeXchange Consortium with 
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1.1 – Escherichia coli – the organism and its characteristics 
Escherichia coli is a gram-negative, rod-shaped bacterium, with peritrichous flagella to propel 
it for movement, and short, “hair-like” pili for attachment to different substrates [1, 2]. It was 
first described by Theodor Escherich, a German paediatrician and microbiologist in 1884, while 
he was conducting research on the bacteria found in the gut of infants [3, 4]. A common place 
to find the bacterium is in faeces, as it colonizes the lower intestine of virtually all mammals 
and a number of other warm-blooded animals. This bacterium is a facultative anaerobe; able to 
utilize oxygen in aerobic respiration, but also perfectly capable of growing without it using 
mixed-acid fermentation. Many traits have made it a favourite among researchers, and the 
preferred bacterial work-horse in molecular biology. It grows quickly on many different 
substrates at 37 °C, and is generally easy to cultivate.  As a member of the phylum 
Proteobacteria, class Gammaproteobacteria, and the family Enterobacteriaceae, E. coli is 
closely related to well-known pathogens such as Klebsiella and Salmonella [5].  
1.1.1 – E. coli as a commensal and pathogenic species  
Despite its more notorious peers, E. coli is most commonly found in humans as a commensal 
bacterium, hitching a ride in the intestinal tract. However, the relationship is mutually 
beneficial, as the bacterium produces vitamin B12 and vitamin K, which humans are unable to 
synthesize for themselves [6, 7]. In addition, by colonizing parts of the gut as a “nice” 
bacterium, it can keep pathogenic microorganisms at bay, simply by taking valuable space on 
the intestinal lining [1].  
In the gut, microorganisms are subject to a myriad of physical forces pushing them around. E. 
coli is able to counteract this by using long, helical flagella moved by rotating motors [2]. They 
can swim in one direction by bundling the filaments and rotating them counterclockwise in a 
coordinated fashion. Change of direction - tumble - can be achieved quickly by rotating one or 
more motors in a clockwise direction [8]. Chemotaxis, the process where a bacterium moves 
towards or away from a chemical gradient is highly reliant on the bacterium’s ability to change 
direction or to keep moving. The gradient is sensed by transmembrane chemoreceptors, methyl-
accepting chemotaxis proteins (MCPs), and relayed to the flagellar motor through Che- and Fli-
proteins [9]. Motility also enables the bacterium to create biofilms: A bacterial community of 
bacteria, colonizing surfaces by enmeshing themselves in a network of adhesins, polymers, and 
extracellular network proteins [10]. A biofilm enables the bacteria to better withstand stress, 
such as environmental fluxes and antibiotics. The cells in the deeper layers of a biofilm are 




keeping in tune with the family relations – also include several strains with a pathogenic 
lifestyle [11]. Pathogenic E. coli can be divided into two main groups, on the basis of where the 
infection is found: intestinal pathogenic E. coli (IPEC), and extraintestinal pathogenic E. coli 
(ExPEC). These groups are further subdivided into pathotypes. A pathotype is defined as “a 
group of strains of a single species with certain pathogenic traits” [11]. The most commonly 
found pathotypes of ExPEC are E. coli causing urinary tract infections; uropathogenic E. coli 
(UPEC), bacteria found in sepsis (blood poisoning); septicemia-associated E. coli (SEPEC), E. 
coli creating illness in birds; avian pathogenic E. coli (APEC), and meningitis-associated E. 
coli (MNEC) [12, 13].  
1.1.2 – E. coli genomics 
Escherichia coli is a bacterium that includes a diverse array of strains, and consequently has a 
very broad genome. It is therefore useful to differentiate between different categories of 
genomes. The all-inclusive pan-genome describes all genes that have been discovered and 
sequenced in bacteria of a specific species. The pan-genome can be further divided into the core 
genome, which encompasses genes that all strains within a species carry, and the accessory, or 
dispensable genome (also known as the flexible genome), which entails genes that are found 
only in some strains [14, 15]. The dispensable genes lend attributes that are not strictly 
necessary for survival, but gives increased fitness under certain conditions and in niches, such 
as antibiotic resistance and virulence factors. The entire pan-genome of  E. coli now includes 
upwards of 16 000 genes [1]. With such a wide variety in the genome, it is a waste of resources 
for one cell to carry the entire pan-genome. An average E. coli genome contains 5000 genes on 
a circular chromosome. Depending on the strain, about two thirds of these are shared with all 
other strains, while one third is part of the accessory genome, and only found in a few, or none, 
other strains [16]. Distantly related strains may share as little as 40 % of their genes [1]. One of 
the most common ways of categorizing E. coli strains have been through serotyping. Using this 
method, three specific surface antigens are used to determine the serotype of the strain; the outer 
core of the lipopolysaccharide layer, the capsular antigen, and proteins from the flagella 
(O:K:H) [17]. This has historically been the most used method, and is useful in vaccine design 
and epidemiological research. Techniques such as multilocus sequence typing (MLST), which 
is based on determining the different alleles of housekeeping genes, may be considered more 
reliable when studying evolutionary relationships, as housekeeping genes are part of the core 




1.1.3 – Extraintestinal pathogenic E. coli  
As already established, pathogenic E. coli can be categorized in many different subtypes. The 
extraintestinal pathogenic E. coli(ExPEC), share the common core genome with all other E. 
coli strains, but have a number of accessory genes that make them well adapted to life as an 
infectious organism, known as virulence factors. These accessory genes enable the bacterium 
to infect the host and avoid the immune system, and are considered virulence factors. Examples 
of virulence factor genes often found in ExPEC strains include machinery for iron uptake, 
adhesins for attachment to cellular surfaces, capsules around the bacteria made of 
polysaccharides, and lipopolysaccharide layers [11, 18-20]. They can be encoded on the main 
chromosome or carried on extrachromosomal plasmids. Often, they are part of mobile genetic 
elements, or have been at some time in the evolutionary past [13]. Being mobile, these genes 
can be transferred between bacteria, creating new strains with a different combination of traits. 
Thus, elucidating the evolutionary relationship between pathogenic E. coli is dependent upon 
robust genetic methods, and cannot rely on a set of specific virulence genes [17]. The current 
methods for assigning E. coli strains to phylogenetic groups, are MLST and quadruplex 
phylotyping [21, 22]. The phylogenetic lineages currently consist of eight defined phylo-
groups: Groups A, B1, B2, C, D, E, F, which are all a part of the E. coli sensu stricto, while the 
eight group, Escherichia cryptic clade I, is not [21]. ExPEC strains are more likely to be 
members of phylogroups B2 or D, than members of A or B1 [23, 24]. According to data 
obtained via MLST, phylogroup B2 is one of the oldest linages in the E. coli phylogenetic tree 
[25]. Like commensal, non-pathogenic strains, ExPEC strains are capable of colonizing the gut 
without causing illness. When they are transmitted to another part of the body, like the urinary 
tract, however, they possess the attributes necessary to invade and cause damage to human cells. 
Genetic analyses have shown that the most prominent sequence types (STs) among ExPEC 
isolates are 69, 73, 95, and 131 [26]. One ExPEC type that is capable of inflicting long-term 
damage, due to the site of infection and the particular vulnerability of the patients, is neonatal 
meningitis-causing E. coli (NMEC). 
1.2 – Neonatal meningitis-causing E. coli  
The spinal fluid circulates around and within the central nervous system, where the brain is 
surrounded by tough membranes known as the meninges: The dura mater, the arachnoid 
membrane, and the pia mater. When bacteria are isolated from the spinal fluid, it is known as 
an inflammation of the meninges – meningitis. Neonates are especially vulnerable to infection. 
Preterm neonates, or infants with a low birth weight, even more so. Preterm neonates are 




underdeveloped immune system. Infants diagnosed with bacterial meningitis are at risk of death 
and neurological sequelae. After group B Streptococcus, E. coli is the second most common 
cause of bacterial meningitis in newborns [27]. E. coli causes approximately 20 - 25% of cases 
of bacterial meningitis in newborns [28, 29]. Of diagnosed cases, approximately 15% of patients 
die, while 30 - 50% suffer disabilities such as intellectual developmental disorders, epilepsy, 
and long-term problems with vision and hearing [29-35]. A study carried out in the United 
Kingdom and Republic of Ireland found that the incidence of neonatal meningitis caused by E. 
coli was 0.04 out of 1000 live births [27].  
1.2.1 – Pathophysiology and infection  
Before meningitis, the patient usually suffers bacteraemia, and a high number of colony-
forming units in the blood are necessary for the bacteria to cross the BBB and invade the 
cerebrospinal fluid   [13, 36, 37]. The infection starts by the bacteria colonizing a mucosal 
surface such as the nasopharynx or gastrointestinal tract, after which they cross the epithelial 
cell layer and enter the bloodstream [36, 38]. The BBB is weakened, and the bacteria induce 
accumulation rearrangement of actin cytoskeleton within the brain microvascular endothelial 
cells (BMECs) [13, 36, 39]. This leads to transcytosis of the bacteria in a closed vacuole through 
a “zipper-like mechanism”. Proteins OmpA and CNF1, along with the K1 capsular antigen, 
have been demonstrated as being vital for attachment and invasion of BMECs [13, 36, 39]. As 
the bacterium usually starts in the blood, bacteremia is detected through blood samples using 
clinical blood cultures. Blood from the patient is drawn in specially made culture bottles 
containing nutrient broth and beads that neutralize antibiotics. The blood culture is incubated 
at 37 °C, and analysed for the presence of bacteria. In order to diagnose meningitis, a sample 
of CSF is acquired through a lumbar puncture. The spinal fluid is analysed, looking for low 
glucose levels and white blood cells. It is also cultivated, so that any bacteria present may grow 
and be identified through PCR. It has been suggested that a source for NMEC is faecal 
transmission of bacteria from healthy carriers, which can be transmitted from the mother to the 
infant during vaginal delivery [37]. Bacterial neonatal meningitis is treated with antibiotics and 
supportive care.  
1.2.2 – NMEC genomics 
The majority of NMEC belong to phylo-group B2, the same evolutionary group as a majority 
of ExPEC strains found in bacteremia and urinary tract infections [37, 40, 41]. When analysing 
a large set of NMEC strains, Bonacorsi and Bingen found that 68% of strains belonged to group 




Wijetunge et al. found a similar distribution of NMEC phylogroup belonging [37]. They also 
found no statistical difference between NMEC and E. coli donated from faecal samples of 
healthy individuals in regards to belonging to group D. Serotype analysis have shown that 
NMEC strains are likely to be of oligoclonal origin [27]. It is not unusual for NMEC strains to 
carry large plasmids containing genes increasing their fitness in a host environment [42]. Genes 
found on 11 plasmids isolated from 9 NMEC strains were shown to carry many genes for iron 
uptake, resistance towards host immunity, and genes for the maintenance of the plasmid itself 
[42]. 
1.2.3 – Other characteristics  
E. coli isolated from the spinal fluid of neonates share many characteristics. More than 80 % 
have the K1 capsular antigen, which is considered a virulence factor [13, 31, 37, 40, 43]. Many 
human cells have glycans – sugar conjugates – on their surface. These glycoconjugates are 
important in many processes, including cell-cell recognition. Sialic acids refer to a wide group 
of nine-carbon sugar acids that are often found in the terminal position of glycoconjugates on 
the surface of human cells, exposed to the environment [44]. Many bacteria have evolved to 
exploit this fact, and include a layer of sialic acid in their outer capsule, which can aid in 
avoiding detection by the innate immune system. E. coli synthesize a large number of capsular 
polysaccharide antigens, K antigens. The K1 capsular antigen is one the most thoroughly 
studied. Bacteria that are serotype K1 synthesize N-acetylneuraminic acid (NeuNAc) in a 
linear, α-2,8-linked homopolymer [45]. In addition to being anti-immunogenic, the K1 capsule 
confers some resistance towards the complement system, has antiphagocytic properties, and 
assists the bacteria in crossing the BBB [45, 46]. The main genes important for K1 polysialic 
acid synthesis are neu- and kps-genes of the kps gene cluster [47]. In a host environment, there 
is little free iron available, and iron acquisition systems such as iroBCDN and iutA increase the 
bacterium’s fitness, and have been found in several NMEC strains [42, 48]. The bacterium may 
also use the host’s heme proteins by expressing the hemin receptor molecule ChuA, giving it a 
an efficient way of obtaining this essential nutrient [49]. NMEC strains have also shown a 
higher frequency of adhesion genes, along with an increased ability to create biofilm when 
compared to non-pathogenic E. coli [24, 37]. Pathogenic E. coli also often secrete toxins such 
as heat-stable enterotoxin a and b, Shiga toxin, and cytolethal distending toxin [13].  
Despite sharing many traits, it is not yet possible to categorize an E. coli strain as an NMEC 
based solely on analysis of the genome, as NMEC strains are varied in what virulence genes 
they possess [40]. However, recent research demonstrates that “virulence genotyping and 




1.3 – Proteomics 
Genomics and proteomics are inseparably linked; without genes, no protein expression. 
However, it has long been clear that we cannot fully understand the proteins, their functions 
and expression solely through studying their genes of origin. And so, proteomics, the study of 
proteins come into play. Since the term was first introduced in 1995, the scientific field of 
proteomics has grown exponentially [50]. As the name implies, proteomics denotes the large-
scale study of proteins, from 3D modelling of single proteins, to whole proteome analysis of 
organelles and cells. The field has branched into many sub-fields, such as the study of post-
translational modifications, protein-protein interactions, structural and functional proteomics, 
and protein expression profiling [50]. All have an important role in biology and often demands 
the mixing of tools and expertise from different fields such as genetics and bioinformatics. The 
synergistic combination of genomics and proteomics has been aptly named proteogenomics, 
and is quickly leading to better annotation of sequenced genomes [51]. 
1.3.1 – Proteomics as a field in microbiology using current techniques 
In microbiology, as in all the biological fields, proteomics has a large role to play. Proteins are, 
after all, how a microorganism interacts with its surroundings. Whether one studies pathogenic 
bacteria – host interactions or commensal microorganisms on plants, protein studies can be vital 
for one’s work. Genomics and transcriptomics can yield valuable information, but do not show 
post-translational modifications, protein turnover, or relative levels of protein expression. 
Microorganisms are extremely good at adapting to their environment and changing which and 
how much proteins they express. The object of one’s study may be one single protein, or one 
can attempt to tie together information about all the proteins expressed by the organism. As 
protein expression can be regulated on the transcriptional, translational, and protein level, one 
cannot use only genetics to study this. One of the fields in proteomics is the study of protein 
expression levels – this involves research into the quantitative amounts of expressed proteins. 
Studying this relies heavily upon integrating earlier work in identifying proteins and their 
functions, and demands highly sensitive methods to detect thousands of proteins at once. One 
can create a “protein profile” for a bacterium. This is an overview of identified proteins, usually 
including their relative levels. A widely used method for large-scale protein analysis has for a 
long time been two-dimensional electrophoresis (2DE), where the proteins are separated based 
on isoelectric point and mass [52]. Other widely used analysis techniques is matrix-assisted 
laser desorption/ionization time-of-flight (MALDI-TOF), a very versatile method that can be 





Today, another method has taken centre stage; liquid chromatography-tandem mass 
spectrometry: LC-MS/MS. This method combines two powerful analysis techniques to create 
a very sensitive and broad detection method. LC, or high-performance liquid chromatography 
(HPLC) is used to separate the different substances suspended in a mixture, creating a 
fractionation of the entire sample. This keeps it from entering the mass spectrometer “all at 
once”. The separation is achieved by pushing the sample through a column, where the 
substances, in this case peptides, are held back to a varying degree. The separation creates a 
precise and orderly elution of the substances, which can then be sent into the mass spectrometer.  
The mass spectrometric analysis is where the detection and measuring of the peptides’ m/z takes 
place. Put simply, the mass spectrometer is able to measure the charge and the mass of a sample. 
It does this by ionizing the sample and turning it into a gas phase, whereupon it injects the 
ionized gas into a detection chamber. Depending on the ration between the ions’ mass and 
charge (m/z ratio), the ions travel to different parts of the detector. The mass spectrometer 
employed in this thesis is an Orbitrap produced by Thermo Scientific with a nano-electrospray 
ion source. An electrospray ionisation uses a strong electrical current to charge the sample 
before it is sprayed in a thin mist and the solvent evaporated. This method of ionisation is well 
suited for the study of biological molecules, as the energy used on each molecule is relatively 
weak, and creates little fragmentation. Strong electrical fields are used to guide and accelerate 
the charged sample to the detection chamber. Orbitrap is an ion trap mass analyser based around 
the principle of confining ions in an oscillating trajectory using an electric field created by ring-
shaped electrodes. The ions are ejected from the trapping cell “in order of increasing m/z ratio”, 
and detected in the ion detector [54, 55]. The instrument also records the number of ions of a 
particular m/z ration per time unit, usually counts per second, with this particular ratio. The 
counts per time unit reflects the abundancy of this particular peptide, and is referred to as 
“intensity”.  With newer technology, tandem mass spectrometry – MS/MS – was introduced. 
Here, ions of interest are analysed more thoroughly by being analysed in sequence: The ion of 
interest, denoted the precursor ion, is analysed once, then fragmented through collision with a 
neutral gas, and the fragment – the product ion – undergoes MS analysis again [56]. This is 
known as collision-induced dissociation. This way, the peptide is analysed twice. The first 
analysis is very precise, and the second somewhat less. MS/MS is still more exact in identifying 
peptides than non-tandem MS. Results of MS analysis are given as mass spectrums, a “graphical 
display of the relative abundance of ion signals against the m/z ratios” [55]. The most intense 




Limitations of MS analysis include a high sensitivity towards contaminants. The method is non-
discriminatory and highly sensitive, so all non-peptide materials that make their way into the 
sample can give disturbances in the final spectra. Common contaminants are keratin from skin 
and hair, and residual chemicals from laboratory equipment. Proper technique, high-quality 
solvents and a clean working environment are all necessary when handling samples for MS 
analysis [57].  
1.3.2 – E. coli proteomics 
As a widely used lab organism and a common human pathogen, there have been many 
proteomic studies of E. coli. There are thousands of studies into the proteins of E. coli, and it 
has become one of the most intensively studied prokaryotes to date. From 3D-modelling to 
sequence analysis and comparison, these studies vary in aims, theme, and methodology. The 
entire E. coli genome has been sequenced, and is well annotated. There are entire databases 
devoted solely to proteins and genes detected in E. coli. A review by Han and Lee considers the 
proteome studies to have moved from gel-based approaches to predictive proteomics using 
bioinformatic tools [58]. They divide today’s research into E. coli proteomics into “proteomics 
for biology and proteomics for biotechnology”. This divides the research based on the intention 
of the studies; if it is done with the intention of improving current knowledge about the 
biological function of the bacteria and proteins, or if it is an attempt at improving production 
and synthesis of bioproducts.   
The work done here falls into the category of “proteomics for biology”. Earlier studies in this 
category include comparative studies growing the bacteria under different conditions, 
assessment of genome coverage using MS, and comparison with transcriptomic data [59-61]. 
These studies usually identify a number of unique proteins ranging from 2600 to 2800, 
depending on how many strains and growth conditions the study included. This constitutes an 
approximate 60 % coverage of the proteins of an annotated genome [60]. Typically, more 
proteins are identified with an increasing number of strains and conditions. A noteworthy study 
executed at Gades Research Group for Infection and Immunity included mass spectrometric 
analysis and comparison of several E. coli strains grown under aerobic and anaerobic conditions 
[59]. Pettersen et al. used LC-MS/MS to create protein profiles of six pathogenic E. coli strains 
and compared relative levels of protein expression in aerobic and anaerobic conditions. This 
thesis follows the same analytical methods and employs the same underlying principles.  
1.3.3 – Bioinformatics 
MS/MS analysis yields enormous amounts of data. The m/z spectra are used to identify specific 




can in turn be mapped to proteins with known sequences. In this thesis, this work is done in the 
program MaxQuant, developed by Jürgen Cox and colleagues at the Max Planck Institute of 
München, Germany [62]. This program employs the search algorithm Andromeda to search for 
and identify the peptides [63]. MaxQuant maps the sequences of detected peptides, and uses 
the levels of these peptides to determine the detected level of the identified protein. As it is 
possible, in fact probable, that the levels of proteins vary between samples due to small 
differences in handling and analysis, a normalization of protein levels is necessary. In order to 
normalize the levels of proteins, a large group of proteins that vary minimally between the 
samples is used as a standard [64]. This is known as Label-Free Quantification (LFQ), as it uses 
no labels, radioactive or otherwise. LFQ uses the signal strength and number of observations of 
frequently detected peptides to create a relative scale. This is used along with an absolute scale 
of summed-up peptide intensities to assign peptides new, normalized intensities; LFQ 
intensities. The LFQ algorithm is integrated into the MaxQuant search engine, and creates two 
distinctive data outputs: the samples without normalized levels, and the same samples with 
levels corrected by LFQ [64]. The resulting data output can be further analysed in Perseus, a 
proteomic analysis program with a range of statistical analysis tools available [65].  
When the proteins have been identified, there are several large databases dedicated to proteomic 
information available. The Universal Protein Resource (UniProt) is one of the decidedly largest, 
and the UniProt KnowledgeBase (UniProtKB) contains millions of protein sequences and 
annotated proteomes of more than 50 thousand species. The database is curated and constantly 
kept up to date [66]. EcoCyc is another database that will be used comprehensively throughout 
this work. It is a database dedicated to the E. coli K12 MG1655, containing experimental 
results, proteomic data, and known biochemical pathways [67]. EcoCyc is a member of the 
broader spanning BioCyc, a collection of species-specific databases dedicated to genomes and 






The main aim of this thesis is to compare the proteomic expression of E. coli strains isolated 
from neonatal meningitis to that of a derivative of a commensal E. coli using mass spectrometry. 
This includes identifying the proteins that differ, what cellular processes they are involved in, 
and the magnitude of difference in expression.  
Sub-aims 
• Genetic and phenotypic characterisation of E. coli strain H622 
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3. Materials and Methods 
Bacterial strains 
E. coli H622 – Isolated at Haukeland University Hospital (Not published) 
E. coli IHE3034 – Kindly donated by Ulrich Dobrindt (University of Münster, 
Germany) 
E. coli J53 – Kindly donated by Ørjan Samuelsen, (UiT The Arctic 
University of Norway). 
E. coli BL21(DE3)pLysS – Commercial product (Promega) 
E. coli ATCC 25922 – Commercial product (American Type Culture Collection 
(ATCC)) 
 
H622 was isolated from a case of neonatal meningitis at Haukeland University Hospital in 2012. 
The strain has not been genome sequenced, nor has it undergone extensive analysis until now. 
IHE3034 (O18:K1:H7) has been genome sequenced (GenBank accession no. CP001969), and 
belongs to multilocus sequence type 95 (ST95) and the EcoR B2 group [20]. 
The E. coli strain J53 (F− met pro) is a derivative of E. coli K12 and has been genome 
sequenced, but the genome has not been assembled. The whole genome shotgun sequencing 
project is available in 42 contigs (GenBank accession no. AICK00000000). It exhibits 
resistance towards sodium azide [69].  
3.1 – Bacterial cell culture 
All work with living bacteria was performed in a Biosafety Level 2 (BSL-2) laboratory, in a 
disinfected class II laminar air flow (LAF) cabinet using gloves and sterile techniques, in 
accordance with UiB’s safety regulations. For storage, the bacteria were kept at -70 °C in 
Greaves’ solution (manufactured by the Substrate lab, Department of Microbiology (MID), 4th 
floor of the Laboratory Building, HUH). 
3.1.1 – Streaking of bacteria from cold storage 
Materials: 
- Agar plates (All agar plates used in this thesis were manufactured by the Substrate lab, 
MID, 4th floor of the Laboratory Building, HUH)  
o Blood agar plate 
o Lactose agar plate (Corresponds to MacConkey agar) 
Bacteria were collected from -70 °C and kept on wet ice. Tubes and plates were only opened 
inside the LAF bench to keep them from being contaminated. Each strain was streaked using 
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dilution streaking and a sterile 1 μl inoculation loop on blood and lactose agar plates. The plates 
were incubated at 37 ° overnight (16 – 18 hrs). 
3.2 – Phenotypic characteristics assay 
A phenotypic characteristics assay is used to determine key metabolic traits of a microorganism, 
such as motility and the ability to utilize certain nutrients. 
The assay was carried out on strains H622, IHE3034 and J53. It was done at the MID at 
Haukeland University Hospital according to their standardized protocols.  
3.3 – Multilocus sequence typing 
Multilocus sequence typing (MLST) is a genetically based method of bacterial strain 
determination and categorization based on variations in the sequence of housekeeping genes. 
Housekeeping genes are involved in basic cellular functions, and are constituents in all strains 
of a bacterial species. These genes are quite stable, and occasional mutation in these genes 
create different versions, known as alleles. In MLST, short stretches of 450-500 base pairs (bp) 
7 housekeeping genes are amplified using PCR and sequenced with Sanger sequencing to 
determine the allele version. The housekeeping genes and their products can be seen in Table 
1. The combination of allele versions is a unique “fingerprint” for the strain, and the basis for 
determining the multilocus sequence type (ST). Determining the ST is important to characterise 
a bacterial strain, and to elucidate the evolutionary relations between different strains [22, 70].  
Table 1 – Seven housekeeping genes used in multilocus sequence typing of E. coli, the primer 
sequences, and the PCR product size [71, 72]. 








































dehydrogenase purA-P2 5′-CATACGGTAAGCCACGCAGA-3´ 







binding motif recAR1 5′-AGCGTGAAGGTAAAACCTGTG-3´ 
 
Materials: 
- Agar plates 
o Blood agar plate 
o Lactose agar plate  
- Bacterial strains 
o IHE3034 
o H622 
- dH2O (Nuclease-free water, Promega) 
- GoTaq Green Master Mix, 2X (Promega) 
- Primers as described in Table 1, 10 μM (Custom made by Sigma-Aldrich) 
- Tris, acetic acid and EDTA (TAE) buffer, pH 8.15 (Substrate lab, MID, 4th floor of the 
Laboratory Building, HUH) 
- Agarose, analytical grade (Sigma-Aldrich)  
- Gel loading dye (Sigma-Aldrich)  
- GeneRuler 1 kb DNA Ladder (Thermo Fisher Scientific) 
- ExoSAP-IT PCR Product Cleanup (Affymetrix)  
- Gelred Nucleic Acid Gel Stain, 10 000X in water (Biotium) 
- Milli-Q water, Type 1 H2O (Purification system: Milli-Q, Merck) 
- BigDye Terminator v3.1 Cycle Sequencing Kit (Thermo Fisher Scientific) 
- Sequencing buffer: BigDye Sequencing buffer 5X (Thermo Fisher Scientific) 
 
Method 
3.2.1 Amplification of housekeeping genes used in MLST via PCR 
The bacterial strains IHE3034 and H622 were streaked on to blood agar plates and lactose agar 
plates and grown over night. An isolated colony was picked from the blood agar plate using a 
sterile 1 µl inoculation loop and transferred to an eppendorf tube with 50 μl dH2O. Lysis of the 
bacteria and pelleting of cell debris was achieved by boiling at 99°C for 15 minutes before 
centrifuging at 16 000 g for 20 minutes. For the PCR amplification, 5 μl of the supernatant from 
each strain was used along with primers and GoTaq Green Master Mix 2X PCR mix. The 
following volumes describe the PCR mix per strain. The given concentration is for the starting 
solutions. 
Component   Volume 
Forward primer, 10 μM 1 μl 
Reverse primer, 10 μM 1 μl 
GoTaq Green, 2X  25 μl  
DNA    5 μl 
dH2O    18 μl 
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Total volume:  50 μl 
The PCR tubes were run in a thermal PCR cycler on the program described in Table 2 
Table 2 – PCR program used in the amplification of seven housekeeping genes. (min: 
minutes, sec: seconds) 
Step Purpose Temperature Time Number of 
cycles 
1 Initialization step 94 °C 5 min 1 
2 Denaturation 94 °C 45 sec 
30 3 Annealing 58 °C 45 sec 
4 Elongation 72 °C 45 sec 
5 Final elongation 72 °C 7 min 1 
6 Final hold 4 °C ∞ 1 
 
After PCR, the samples were stored at 4 °C over night. 
3.2.2 Gel electrophoresis of PCR products 
A 2 % (w/v) agarose gel was created by heating 3 gr agarose and 150 ml TAE buffer, and the 
liquid agar cast in a gel mould. To weight the sample and facilitate loading, 1 μl gel loading 
dye was mixed with 5 μl PCR product. The gel was submerged in TAE buffer, and the samples 
loaded along with a 1 kb DNA marker, before the gel was run at 120 V for 60 minutes. In order 
to visualize the bands, the gel was soaked in a solution of 50 μl GelRed in 100 ml MilliQ H2O 
for 40 minutes using mild agitation.  The gel was rinsed and destained in Milli-Q water 5 
minutes, 3 times, with a change of water per destaining. The gel was visualized in a UV 
transilluminator. 
3.2.3 Clean-up of PCR products  
The resulting DNA was cleaned; single nucleotides and single-stranded DNA was removed, by 
using ExoSAP-IT; 5 μl PCR product was combined with 2 μl ExoSAP-IT and incubated at 37 
°C for 15 minutes before inactivation of the ExoSAP-IT at 80 °C for 15 minutes. 
3.2.3 Sanger sequencing and analysis 
This procedure is based upon the one created by the Sequencing Facility at the University of 
Bergen [73]. In order to obtain precise sequencing results, the sanger dideoxy sequencing was 
carried out using both the reverse and the forward primer for all the seven genes. A Qubit 
Fluorometric Quantitation (Thermo Fisher Scientific) fluorometer was used to determine DNA 
concentration of the samples. The same primers were used as for the previous amplification, 
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and the primers were diluted to a concentration of 3.2 µM using dH2O. The samples were 
sequenced with forward and reverse primers separately, giving a total of 14 samples per 
bacterial strain. The sequencing mix described below was run in a PCR thermal cycler at the 
program described in Table 3. The given concentration is for the solutions before they are 
mixed. DNA implies inactivated PCR and ExoSAP-IT mix: 
Component   Volume 
BigDye v.3.1   1 μl 
Sequencing buffer   1 μl 
DNA    3 μl 
Primer, 3.2 μM  1 μl 
dH2O    4 μl 
Total volume:  10 μl 
 
Table 3 – PCR thermal cycler program for the sequencing of seven amplified housekeeping 
genes used to determine sequence type. (min: minutes, sec: seconds) [73].  
Step Purpose Temperature Time Number of 
cycles 
1 Initialization step 96 °C 5 min 1 
2 Denaturation 96 °C 10 sec 
25 3 Annealing 55 °C 5 sec 
4 Elongation 60 °C 4 min 
5 Final hold 4 °C ∞ 1 
 
When the cycler was finished, 10 μl dH2O was added to each sample before they were sent for 
analysis at the sequencing unit at the University of Bergen [73]. The MLST database of 
University of Warwick was used to determine the allele version of each gene, and the ST [74].  
3.4 – Phylogenetic grouping protocol 
E. coli can be grouped and characterised in many ways. An important aspect of E. coli research 
is the categorization of different strains and determination of evolutionary relations. In 2000, 
Clermont et al. developed a phylo-typing method known as the triplex PCR method, which 
could group strains into subgroups A, B1, B2, or D. This was based on the presence or absence 
of three PCR products from the genes chuA and yjaA, and a DNA fragment known as TspE4.C2 
[75]. All primers are mixed in with the sample before cycling, and the presence of DNA 
fragments of specific sizes is considered a positive (+) or a negative (-) presence of the gene. 
The pattern of which genes are present form the basis of phylo-typing the bacterial strain. 
3. Materials and Methods 
24 
 
Extensive research has led to the establishing of a total of 8 phylo-groups of E. coli, of which 
seven (A, B1, B2, C, D, E, F) belong to the E. coli sensu stricto, and one is known as 
Escherichia clade I. Clermont et al. has developed a new method based upon the triplex PCR, 
with the inclusion of a fragment from the gene arpA [21]. This makes the method a quadruplex 
PCR method, and further refines its ability to discriminate between groups (Table 4). 
Table 4 – Primer sequences and product size for the primers used in phylogenetic grouping  
[21, 75]. 








ChuA.1 5´-GACGAACCA ACGGTCAGGAT-3´ 
279  
ChuA.2 5´-TGCCGCCAGTACC AAAGACA-3´ 
yjaA 









- Agar plates 
o Blood agar plate 
o Lactose agar plate  




- dH2O (Nuclease-free water) 
- GoTaq Green Master Mix, 2X  
- Primers as described in Table 1, 10 μM (Custom made by Sigma-Aldrich) 
- Tris, acetic acid and EDTA (TAE) buffer, pH 8.15 
- Agarose, analytical grade  
- 100 bp DNA Ladder (N32315, New England Biolabs) 
- Gelred Nucleic Acid Gel Stain, 10 000X in water 
- Milli-Q water, Type 1 H2O  
 
Method 
The bacterial strains H622, IHE3034 and J53 were grown and lysed as described in section 
3.2.1. From this sample, 5 μl of the supernatant from the sample (DNA) was transferred to a 
sterile eppendorf tube and mixed with primers, GoTaq Green Master Mix 2X, and nuclease-
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free water as described below. The given concentration is for the solutions before they are 
mixed. 
Component   Volume 
Primer AceK.f, 10 μM 1 μl 
Primer ArpA1.r, 10 μM 1 μl 
Primer ChuA.1, 10 μM 1 μl 
Primer ChuA.2, 10 μM 1 μl 
Primer YjaA.1, 10 μM 1 μl 
Primer YjaA.2, 10 μM 1 μl 
Primer TspE4C2.1, 10 μM 1 μl 
Primer TspE4C2.2, 10 μM 1 μl 
GoTaq Green, 2X  25 μl 
DNA    5 μl 
dH2O    12 μl 
Total volume:  50 μl 
The samples were amplified in a PCR thermal cycler using the program described in Table 5. 
Table 5 – Table describing the PCR thermal cycler program used in the amplification of DNA 
fragments for use in phylo-typing of E. coli.  
Step Purpose Temperature Time Number of 
cycles 
1 Initialization step 94 °C 5 min 1 
2 Denaturation 94 °C 45 sec 
30 3 Annealing 58 °C 45 sec 
4 Elongation 72 °C 45 sec 
5 Final elongation 72 °C 7 min 1 
6 Final hold 4 °C ∞ 1 
 
A 2 % (w/v) agarose gel was created as described earlier, and submerged in TAE buffer. The 
samples were loaded along with a 100 bp ladder and run at 120 V for 60 minutes. The gel was 
stained in GelRed, destained and visualized as described earlier. 
3.5 – Antibiotic susceptibility testing by disc diffusion 
A standard method for determining the antibiotic susceptibility of a strain is by disc diffusion 
[76, 77]. A paper disc saturated with a known quantity of antibiotics is placed on the surface of 
an agar plate inoculated with a bacterium, and the antibiotic diffuses through the agar. After 
incubation, an area with no growth around the disc can be seen if the bacteria have responded. 
The size of the zone of inhibition represents the in vitro efficacy of the tested drug. The 
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European Committee on Antimicrobial Susceptibility Testing (EUCAST) have standardized 
the methods and resistance determinants, including breakpoint tables for antibiotics and 
microorganisms [78, 79].  Bacterial resistance levels are based on the diameter of the inhibitory 
zone. Using clinical breakpoint tables devised for species and antimicrobial agent, one can 
categorize the bacteria as susceptible (S), intermediate resistant (I), or resistant (R) [80]. These 




- Agar plates (Substrate lab, MID, 4th floor of the Laboratory Building, HUH) 
o Blood agar plate 
o Lactose agar plate 
o Mueller-Hinton agar 
- Antibiotics 
o MIC test strip (Liofilchem):   Gradient: 
▪ Ampicillin    0.016 – 256 µg/ml 
▪ Cefotaxime    0.016 – 256 µg/ml 
▪ Ceftriaxone    0.016 – 256 µg/ml 
▪ Ciprofloxacin    0.002 – 32 µg/ml 
▪ Gentamicin    0.016 – 256 µg/ml 
o Discs (Oxoid):    Antibiotic per disc:  
▪ Ampicillin    10 µg 
▪ Cefotaxime    5 µg 
▪ Gentamicin    10 µg 
▪ Ciprofloxacin    5 µg 
▪ Cefuroxime    30 µg 
▪ Amoxicillin-clavulanate  20/10 µg 
▪ Ceftazidime    10 µg/disc 
▪ Ertapenem     10 µg/disc 
▪ Meropenem     10 µg/disc 
▪ Imipenem     10 µg/disc 
▪ Trimethoprim-sulfamethoxazole 1.25/23.75 µg/disc 
▪ Piperacillin-tazobactam   30/6 µg/disc 
Method 
E. coli ATCC 25922 was chosen as quality control strain in accordance with EUCAST 
guidelines [81]. The bacteria were brought from – 70 °C storage, streaked onto blood agar and 
lactose agar plates and incubated overnight at 37 °C. Colonies were picked from the blood agar 
plate and suspended in physiological saline (NaCl 0.09 % (w/v)) to a density of 0.5 McFarland 
(± 0.05). Within 15 minutes, a sterile cotton wad was dipped in the solution and pressed against 
the side of the tube to remove excess inoculum. To create an even carpet growth of bacteria, an 
automatic rotator was used to spin the Mueller-Hinton agar plates and the cotton wad moved 
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from the edge of the plate to the centre. A maximum of 6 discs or 2 strips were applied to each 
agar plate before 15 minutes passed since streaking. All plates were incubated at 37 °C for 18 
hours. No more than four plates were placed in each stack. 
Reading the plates: 
Discs: Inhibition zone diameter was measured using a slide calliper on the back of the plate, 
using the naked eye and held against a black background approximately 30 cm from the eyes. 
If the zone was divided by a weaker line, giving an inner and outer zone, the inner border was 
registered. 
Strips: MIC was determined by finding where the zone of inhibition fell on the strip. If this 
point fell between two MIC concentrations, the most stringent concentration was chosen. I.e., 
if the point fell between 8 and 6, one would round up to 8. 
3.6 – Growing bacterial cells in blood culture, purification and lysis 
Before LC-MS/MS analysis, the bacteria were grown in clinical blood culture, lysed, and the 
proteins digested using proteases. 
3.6.1 – Preparation of bacterial samples for MS/MS analysis 
Materials 
- Agar plates 
o Blood agar plate 
o Lactose agar plate  




- Tris-buffered saline (TBS) (Substrate lab, MID, 4th floor of the Laboratory Building, 
HUH) 
- Blood lysis buffer 
o 0,6 % (w/v) Brij 97 (Polyoxyethylene (10) oleyl ether) (Sigma-Aldrich), 0.4 M 
CAPS (3-(Cyclohexylamino)-1-propanesulfonic acid) (Sigma-Aldrich), pH 
11.7 
Filtered through a sterile 0.2 µm pore filter 
- Bacterial washing buffer 
o 20 mM sodium phosphate dibasic (ICN Biomedicals), 0.05 % (w/v)  Brij 97, 
0.45 % (w/v) NaCl (Sigma-Aldrich), ph 7.2 
Filtered through a sterile 0.2 µm pore filter 
- Bacterial extraction buffer  
o 2,5 % SDS (w/v) (Invitrogen), 10 mM Tris-HCl (Sigma-Aldrich) 
The bacteria were streaked on blood agar plates and incubated overnight at 37 °C. A healthy 
volunteer donated 10 ml blood to each of six clinical blood culture bottles (aerobic 
BacT/ALERT FA Plus (Biomérieux #410851). These clinical blood cultures are the ones used 
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in hospital to screen for bacteremia. Biological replicas were created by inoculating each strain 
in two separate blood culture bottles. For the inoculum to be created, room temperature (RT) 
physiological saline was used. Three well-isolated, medium-sized colonies were picked and 
completely suspended in 3 ml saline. The blood cultures were inoculated with 0.5 ml of the 
suspension, before being incubated in the automated blood culture system BacT/ALERT 3D 
(Biomérieux) at 36 °C for 14 hours. When taken out of the incubator, the blood cultures sat at 
RT for approx. 2 hrs, and at 4 °C for 2 hrs, before treatment.  
3.6.2 – Purification of bacterial cells from blood culture 
As it is only the bacterial proteins that are of interest, it is important to extract and rinse the 
bacteria from the blood culture before lysis. This way, one lessens the risk of human proteins 
contaminating the sample.  
The blood lysis buffer lyses human blood cells, but leaves bacterial cells intact. That way, the 
sample can be centrifuged, and the microorganisms collected. From each clinical blood culture, 
30 ml of blood broth was taken. The broth was lysed by mixing 30 ml blood culture broth and 
15 ml blood lysis buffer. The solution was incubated at RT for 5 minutes, before being 
centrifuged at 1800 RCF. Post centrifugation, the supernatant was removed and the pellet 
inspected. The pellet in all tubes had red discolouration, and was resuspended in 5 ml blood 
lysis buffer, incubated for 5 minutes and centrifuged at 4600 rpm in a Heraeus Multifuge 3SR 
with a swing-out rotor 4 place. A red-coloured edge could be seen in the top of the pellet, this 
was gently removed with a sterile pipette. The bacterial pellet was washed by resuspension in 
10 ml washing buffer, and centrifuged at the same conditions for 4 minutes. This was done a 
total of 3 times. Following the washing step, the pellet was resuspended in 10 ml tris-buffered 
saline (TBS) and centrifuged at the same conditions. Post centrifugation, the supernatant was 
removed, and the process repeated. The pelleted bacterial cells were resuspended in 1 ml TBS 
and transferred to the eppendorf tube before being centrifuged for 2 minutes 18 000 RCF. The 
supernatant was removed, and the pellet frozen over night at -70 °C. 
Extraction of bacterial proteins for MS/MS analysis 
The samples were kept on wet ice when not handled. 
The pellet was resuspended in 750 μl bacterial extraction buffer. The solution was transferred 
to a 2 ml screw cap tube (FastPrep Lysing Matrix A (#116910050, MP Biomedicals)) and the 
bacterial cells were disrupted in a ribolyser (FastPrep-24, QBiogene Inc.) for 60 seconds at 
maximum speed (6,5 m/s). The samples were incubated on ice for five minutes, before 
centrifugation for 45 minutes at 4 °C and 10 000 RCF. To clear the supernatant of particulates, 
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300 µl of the supernatant was transferred to a clean eppendorf tube and centrifuged in an 
eppendorf centrifuge for 5 minutes at 4 °C and 20 000 RCF. Direct Detect (EMD Millipore) 
was used to determine the protein concentration of the supernatant. From this point onwards, 
all samples were treated in triplicate. At the end of the procedure, two of the replicas were sent 
to the MS analysis, while a third was kept at – 70 °C, as a backup. 
3.6.3 – Pre-enzymatic and enzymatic steps in preparation of MS/MS analysis 
The proteomic sample preparation was done according to the Multi-Enzyme Digestion, Filter-
Aided Sample Preparation (MED-FASP) procedures, as described by Wiśniewski et al. [82, 
83]. In this procedure, the samples are digested using two proteases consecutively. The FASP 
procedure is carried out within the confines of a membrane, which acts as a miniature reactor 
for the digestion. The membrane retains larger molecules, such as DNA and undigested 
proteins, while letting peptides and smaller contaminants through. This enables the digestion of 
proteins directly on top of the membrane. By using the FASP method, one bypasses the in-
solution or in-gel digestion methods usually used for digestion of proteins before MS-analysis. 
This method has also been demonstrated as very robust when dealing with smaller amounts of 
protein. It typically converts approximately 50 % of the available proteins to peptides, and 
facilitates easy rinsing of the samples to remove detergents [82, 83]. 
In bottom-up proteomic experiments such as this, the goal of the enzymatic digestion is to 
reduce the proteins to peptides that are small enough to ionize and analyse via MS. In addition 
to digesting the proteins on a membrane, they were digested using two enzymes. Done 
correctly, this creates a broader coverage of digested peptides than digestion with only one 
enzyme, or digestion with several enzymes separately [83]. The use of different enzymes 
creates peptides cut in different places, and a more precise identification of proteins using 
overlapping peptide sequences. According to Wiśniewski et al., the choice of enzymes that gave 
the highest number of unique identifications of peptides were digestion using LysC followed 
by digestion with trypsin. The LysC used here is an endoproteinase that cleaves at lysine 
residues, including those followed by a proline. Trypsin is a serine endoproteinase with 
cleavage action on the C-terminal side of arginine and lysine residues. 
All work pertaining enzymes and preparation for enzymatic digestion were done in a clean and 
semi-closed cabinet, protected from atmospheric dust and contamination. All reagents were of 
MS-grade. 




- Microcon®-30 centrifugal filter units with a molecular cutoff of 30 000 Dalton (EMD 
Millipore) 
- Chromasolv MS grade H2O (Sigma-Aldrich)  
- DTT-AmBic solution 
o 10 mM Dithiothreitol (DTT) (Sigma-Aldrich), 100 mM ammonium 
bicarbonate (Sigma-Aldrich)  
Kept on wet ice  
- UA solution  
o 8 M urea (Sigma-Aldrich), 10 mM HEPES (Sigma-Aldrich), pH 8 
- IAA solution 
o 0.05 M iodoacetamide in UA solution 
Kept dark at all times 
- Enzymes 
o LysC 
▪ Lysyl endopeptidase, MS grade, 20 µg (Wako, Catalogue # 121-05063) 
o Trypsin 
▪ Pierce trypsin protease, MS grade, 20 µg (Thermo Fisher Scientific, 
Catalogue # 1862748) 
- Tris-HCl (Sigma-Aldrich) 
Denaturation of proteins 
In order to achieve efficient enzymatic cleavage of proteins into peptides, the proteins were 
denatured using sodium dodecyl sulphate (SDS) and dithiothreitol (DTT). SDS has strong 
denaturing effects due to its numerous negative charges. DTT reduces disulphide bonds, and 
keeps the protein from reforming its secondary structure. As the digestive enzymes are unable 
to cleave proteins that are tightly folded, denaturing is used to cause the proteins to lose their 
tertiary structures, thus exposing restriction sites for the enzymes to cut. Strong denaturing 
conditions also render the proteins stable, and keep them from refolding. Thiol groups were 
alkylated to prevent reformation of disulphide bonds by adding iodoacetamide. 
The FASP method was followed [82], using Microcon®-30 centrifugal filter units with a 
molecular cutoff of 30 000 Dalton. 
For each sample, 50 µg was used, and diluted to 50 µl with Chromasolv MS grade water. To 
reduce the disulphide bonds and raise the pH, 5 µl DTT-AmBic solution was added and the 
samples incubated for 45 minutes at 56 °C with mixing of 350 rpm. The spin filters were 
assembled and recieved 100 µl UA solution before being spun at 14 000 RCF for five minutes 
at RT. The protein sample received 200 µl UA solution, was transferred to the spin filter and 
centrifuged at 14 000 g for 15 minutes. Another 200 µl UA solution was added to the filter 
before centrifuging at the same conditions, and the flow-through discarded. The filter unit 
received 100 µl IAA solution and was incubated in darkness for 20 minutes with 300 rpm 
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shaking at RT. The samples were centrifuged at 14 000 g for 10 minutes. 100 µl UA solution 
was added, and the samples were centrifuged at 14 000 g for 15 minutes. This was repeated 
twice. 
Enzymatic digestion of protein samples using LysC 
Each filter unit received 100 µl 50 mM Tris-HCl and centrifuged at 14 000 g for 10 minutes. 
This was done a total of three times. The collection tube was changed to a fresh one. To 
resuspend the lyophilized enzyme, 1020 µl 50 mM Tris-HCl pH 8 was added and the solution 
vortexed. 50 µl enzyme suspension was added to each filter unit and the samples were placed 
in a thermo mixer for 60 seconds at 600 rpm. The samples were transferred to an incubator 
along a bowl of water to keep the humidity high. They were incubated at 30 °C for 13 hours. 
The samples were centrifuged at 14 000 g for 15 minutes. 50 µl MS grade H2O was added, and 
the samples centrifuged using the same conditions. This was repeated once. The filter units with 
the remaining proteins were transferred to new collection tubes and placed on wet ice. The 
collection tubes containing eluate were placed in a SpeedVac (Eppendorf Concentrator Plus), 
and run at 30 °C until approx. 20 µl solution was left. The samples were treated using STAGE 
tips, see section 3.6.4. 
Enzymatic digestion of protein samples using trypsin 
The trypsin enzyme was resuspended using 1020 µl 40 mM AmBic and vortexed before each 
filter received 50 µl of the resuspended enzyme. The samples were mixed in a thermo mixer 
for 60 seconds at 600 rpm. The filter units were incubated on wet ice for 2.5 hours. The same 
wet chamber was used as previously, including a bowl of water to keep the humidity high. 
The samples were incubated at 37 °C for 12 hours. In order to collect the peptides, the 
samples were centrifuged at 14 000 g for 15 minutes. The remaining peptides were eluted by 
adding 50 µl H2O and centrifuging for 15 minutes at 14 000 g. This step was repeated once. 
The collection tubes were placed in a SpeedVac, and run at 30 °C until approx. 20 µl solution 
was left. The samples were treated using STAGE tips, see section 3.6.4. 
 
3.6.4 – Stop and Go (STAGE) Extraction Tips  
Materials: 
- Micropipette tip, 2-200 µl (Eppendorf)  
- Cutting tool  
- Syringe, 1 ml 
- C18 Empore filters (Varian, 3M) 
- LoBind tubes for proteins (Eppendorf)  
- Acetonitrile, LC-MS Chromasolv (Fluka) (ACN) 
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- Formic acid (Sigma-Aldrich) (FA) 
o 0.1 % FA, diluted in Chromasolv H2O (v/v) 
o 0.1 % FA in 80 % ACN, diluted with Chromasolv H2O (v/v) 
- Methanol, Chromasolv (Sigma-Aldrich) 
Method 
The method of Rappsilber et al. [84] was followed to create micro tips with stacked filter 
material for cleaning peptides. The membrane consists of reverse-phase beads immobilized in 
a polytetrafluoroethylene mesh. The chromatographic beads are able to bind the peptides, which 
can be washed of all contaminants using the correct solvents, before being eluted. Small, 
circular pieces of membrane can be cut out and stacked in micropipette tips using an appropriate 
cutting tool, like a blunt-ended syringe. Each circular disc is able to hold 2 to 4 µg of peptide 
[84]. Because of the tapering of the micropipette tip, the membrane disks are immobilized and 
do not fall through. This makes them able to withstand relatively high pressure. Exploiting this, 
an air-filled syringe with the correct adapter is used to push the solutions through the stacked 
discs. A high dilution of formic acid (FA) is used to wash away contaminants. Acetonitrile 
(ACN) is a solvent used to elute the peptides from the STAGE tip. 
Using the cutting tool, 6 discs of C18 Empore filters were cut out and gently packed into a 2-
200 µl micropipette tip. The following was added and subsequently pushed through the filters, 
using the syringe to create air pressure: 
i. 20 µl methanol 
ii. 20 µl 0.1 % FA in 80 % ACN 
iii. 20 µl 0.1 % FA 
iv. Sample 
v. 20 µl 0.1 % FA – Pushed into waste 
vi. 40 µl 0.1 % FA in 80 % ACN, and the eluate collected into LoBind 
tubes. 
The samples were dried in a SpeedVac at 30 °C, and stored at -70 °C. Before analysis, the 
peptides were resuspended 0.1% formic acid and 2% ACN. 
 
3.7 – LC-MS/MS 
The LC-MS/MS analysis was done at the Proteomics Unit at the University of Bergen  in the 
exact manner as described in the paper by Pettersen et al. [59]: 
“The MS/MS analysis was carried out at the Proteomics Unit at the University of Bergen on an 
Ultimate 3000 RSLC system (Thermo Scientific, Waltham, MA) connected to a LTQ Orbitrap 
i., ii., and iii.: Pushed 
through and sent in 
waste 
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mass spectrometer (Thermo Scientific) equipped with a nanoelectrospray ion source. Briefly, 
0.5–1 µg protein was loaded onto a preconcentration column (Acclaim PepMap 100, 2 cm × 75 
µm ID nanoViper column, packed with 3 µm C18 beads) at a flow rate of 5 µl/min for 5 min 
using an isocratic flow of 0.1% TFA [trifluoroacetic acid] (v/v) with 2% ACN (v/v). Peptides 
were separated during a biphasic ACN gradient from two nanoflow UPLC pumps (flow rate of 
270 nl/min) on the analytical column (Acclaim PepMap 100, 50 cm × 75 µm ID nanoViper 
column, packed with 3 µm C18 beads). Solvent A and B was 0.1% TFA acid (v/v) in water or 
ACN, respectively. Separated peptides were sprayed directly into the MS instrument during a 
195 min LC run with the following gradient composition: 0–5 min 5% B, 5–6 min 5–7% B, 6–
135 min 7–32% B, 135–145 min 32—% B, 145–150 min 40–90% B. Elution of very 
hydrophobic peptides and conditioning of the column was performed by isocratic elution with 
90% B (150–170 min) and 5% B (175–195 min), respectively. Desolvation and charge 
production were accomplished by a nanospray Flex ion source. 
The mass spectrometer was operated in data-dependent-acquisition mode to automatically 
switch between Orbitrap-MS and LTQMS/ MS acquisition. Survey of full-scan MS spectra 
(from m/z 300 to 2000) were acquired in the Orbitrap with resolution of r = 240,000 at m/z 400 
(after accumulation to a target of 1,000,000 charges in the LTQ). The method used allowed 
sequential isolation of the most intense ions (up to 12, depending on signal intensity) for 
fragmentation on the linear ion trap using collisionally induced dissociation at a target value of 
10,000 charges. Target ions already selected for MS/MS were dynamically excluded for 40s. 
General MS conditions were as follows: electrospray voltage, 1.8 kV; no sheath; and auxiliary 
gas flow. Ion selection threshold was 3000 counts for MS/MS, and an activation Q-value of 
0.25 and activation time of 10 ms was also applied for MS/MS.” 
 
3.8 – Pulsed-Field Gel Electrophoresis 
Pulsed-field gel electrophoresis (PFGE) is a method for the separation of larger DNA 
fragments. While smaller fragments are easily separated by regular gel electrophoresis, large 
DNA fragments (> 20 kb) clump together and form one cohesive band. In PFGE, the direction 
of the current is varied, and switches between straight down, perpendicular to the axis. The 
constantly changing current creates a much better separation of larger DNA fragments, such as 
large plasmids [85]. Large plasmids are sensitive towards fragmentation, and so the bacteria are 
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cast inside gel plugs. Immobilized in the agarose gel plugs, lysis of the cells and digestion of 
the DNA using nuclease can take place without risking the DNA clumping or being torn apart. 
Materials: 
- TE buffer 
o 10 mM Tris, 1 mM EDTA, pH 8 
- TBE (Tris, borate, EDTA) buffer (Substrate lab, MID, 4th floor of the Laboratory 
Building, HUH) 
- SeaKem Gold agarose (Lonza) 
- Proteinase K, 20 mg/ml (Thermo Fisher Scientific) 
- Cell Suspension Buffer 
o 100 mM Tris, 100 mM EDTA, pH 8 
- S1 endonuclease (100 U/µl) (Thermo Fisher Scientific, Catalogue # EN0321) 
- Restriction buffer for S1 endonuclease (5x) (Thermo Fisher Scientific) 
- Chromasolv H2O (Sigma-Aldrich)  
- GelRed (Biotium) 
The equipment used for running the PFGE was a CHEF-DR III (Bio-Rad), assembled according 
to the manufacturer’s instructions.  
Method  
The PFGE was carried out by following the Standard Operating Procedure for PFGE of E. coli 
O157:H7 and non-O157 [86]. 
The settings for the running of the gel were the following: 
- The cooling device was set to 14 °C 
- 2 L 0.5x TBE buffer was poured into the cooling device 
- The flow rate of the pump was set to 1 L / minute 
- The pump was turned on, and (volume) 0.5x TBE buffer was added 
- The cooling device was run for 30 minutes before the gel was submerged in the holder 
- The following settings were used: 
o Initial switch time 1 seconds 
o Final switch time 25 seconds 
o Runtime 24 hours 
o Angle 120° 
o Gradient 6V/cm 
o Temperature 14 °C 
o Ramping factor linear 
The gel was stained using intercalating dye (GelRed) and visualized in a UV transilluminator. 
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3.9 – Investigating the presence of smaller plasmids in H622 
In order to determine whether the bacterial strain harbours any smaller plasmids, a plasmid 
extraction was carried out. An E. coli strain with a known presence of a small plasmid was used 
as positive control. Size and presence of DNA was verified by running an agarose gel 
electrophoresis. 
Materials: 
- Kit: QIAGEN Plasmid Midi Kit (Cat No./ID: 12143) 
- Bacterial strains: 
o H622 
o BL21(DE3)pLysS 
▪ An E. coli strain containing the plasmid pLysS (approximately 4.8 kb).  
- S1 endonuclease (100 U/µl) (Thermo Fisher Scientific, # EN0321)  
- Restriction buffer for S1 endonuclease (5x) (Thermo Fisher Scientific) 
- Agarose (SeaKem) 
- TAE buffer (Substrate lab, MID, 4th floor of the Laboratory Building, HUH) 
- DNA marker: EZ load 1 – 15 kb (BioRad) 
- GelRed (Biotium) 
Method: 
The procedure to extract plasmids was carried out according to the instructions included in the 
kit. Post extraction, the DNA was cut using an S1 endonuclease. A negative control containing 
TE buffer in place of DNA was run alongside the samples. A Nanodrop 2000 spectrophotometer 
(Thermo Fisher Scientific) was used to determine DNA concentration in the samples. 
Recipe for enzymatic digestion:  
S1 nuclease: 1 µl (5U/µl) 
S1 buffer (5x): 4 µl 
DNA: 200 ng 
dH2O ad 20 µl 
The reaction was run for 1.5 hours on 37 °C. 
Agarose gel electrophoresis of samples and staining in GelRed 
A 0.8 % (w/v) agarose gel in TAE buffer was used, and 5 µl of EZ load 1 – 15 kb was loaded 
next to the samples. The gel was run at 120 V for 1 hr 10 min. It was stained in a GelRed 
solution (120 µl in 500 ml) for 2 hours and visualized in a UV transilluminator.  
 
3.10 – Computational analysis of MS results 
Software: 
- Chromas Lite, v2.1, Developed by Technelysium 
- MaxQuant, v1.5.5.1, J. Cox et al. [62] 
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- Perseus, v1.5.6.0, Tyanova et al. [65] 
- Excel, various versions (Microsoft Office) 
Procedure: 
Protein detection using MaxQuant 
The raw files from the LC-MS/MS were analysed using MaxQuant version 1.5.5.1 [62] and the 
integrated Andromeda search engine [63] with the following databases: Reviewed E. coli 
proteins were downloaded from the Swiss-Prot section of UniProtKB (28,709 entries, 
downloaded on the 15th September 2016). MaxQuant was used to create a six-frame translation 
of the following genomes: NMEC strain IHE3034 (NCBI Reference Sequence: NC_017628.1, 
28,998 entries for chromosome), and plasmid pRS218 (NCBI Reference Sequence: 
NZ_CP007150.1; 3,329 entries for plasmid) from the NMEC strain RS218. Along with the 
experimental raw files of H622, IHE3034 and J53, raw files from a completed experiment in 
the same research group were run, where IHE3034 and J53 were grown on blood agar and the 
proteins digested as described here. The mass spectrometry proteomics data have been 
deposited to the ProteomeXchange Consortium via the PRIDE partner repository with the 
dataset identifier PXD005779, and will be made accessible upon publication [87]. Parameters 
used in the MaxQuant search were the standard settings, save the following: 
- Lysine acetylation and glutamate/glutamine conversion to pyro-glutamate were defined 
as variable modifications, along with N-terminal acetylation and methionine oxidation. 
- “Match between runs” was enabled, and group-specific parameters included defined 
enzyme specificity of trypsin or LysC, with N-terminal cleavage to proline. 
Using two digestive enzymes gives a deeper coverage of protein fragments. In order to utilize 
this, the spectra were combined for the replicas digested with different enzymes. Allowed 
fragment mass tolerance value was set to a maximum of 0.50 Da, and the initial mass deviation 
of the precursor ion was not allowed to exceed 20 ppm. For both proteins and peptides, 
maximum false discovery rate (FDR), was set to 0.01. Label-free quantification (LFQ) 
algorithms within MaxQuant, MaxLFQ, were used to create the normalized protein intensities. 
They were normalized in relation to the levels of common proteins in a sample [64]. The LFQ 
values – “LFQ intensity” – have been used for statistical analysis, while the unnormalized 
spectra – “Intensity” – have been solely used to detect the presence of proteins within a sample. 
Completing the identification of proteins 
The resulting proteins and peptides were exported to Microsoft Excel in separate documents. 
The mapping of proteins lacking gene names and/or UniProt IDs was completed using protein 
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BLAST (https://blast.ncbi.nlm.nih.gov/Blast.cgi?PAGE=Proteins). The amino acid sequence 
as defined by MaxQuant was exported to BLAST and a search was run. Only proteins that 
showed a 100% similarity with the amino acid sequence were considered, and the protein was 
chosen based on BLAST’s own ranking. The information was exported and included in the 
established Excel document for proteins.  
Using a Pearson correlation to determine correlation of intensities and LFQ intensities 
between replicas 
For each strain, two blood cultures were inoculated creating biological replicas A and B. Each 
biological replica was treated in duplicate, creating replicas A1, A2, B1 and B2. To quantify 
the similarity between replicas, and establishing a base for examining how close they are, the 
Pearson correlation coefficient R was found for each strain and growth conditions. E.g., all 
replicas from H622 grown in blood culture were compared to each other, all replicas from 
IHE3034 grown on blood agar were compared to each other, but not to the replicas of IHE3034 
grown in blood culture, they were analysed separately. The Pearson correlation coefficient was 
established for the intensities and the LFQ intensities by using Perseus: All values were 
transformed to log2, and a multi scatter plot of all replicas from one strain and conditions was 
created. In Perseus, one has the option of “Show Pearson correlation” for each scatter plot. 
Filtering of proteins: Removing duplicates and proteins with very low scores 
Filtering of protein duplicates was done by first identifying all proteins that shared the same 
gene name. This was done via Excel’s innate “Find duplicates” function. As all peptides 
identified by MaxQuant receives a unique peptide ID, the peptide IDs by which they were 
identified could be compared. If double identification could be ascertained, the protein with the 
combination of lowest score, MS/MS count, and lowest number of unique and “razor” was 
deleted from the results. If the proteins shared gene names, but could not be ascertained as being 
duplicate identifications, the amino acid sequences were compared using protein BLAST. If the 
BLAST comparison showed that they did not share amino acid sequence, none were removed. 
Proteins only identified by site, or containing peptides that were flagged by MaxQuant as either 
contaminants or reverse sequence, were removed. Peptides belonging to removed proteins were 
deleted from the results. All proteins that were identified by MaxQuant to have a species of 
origin other than Escherichia coli, Shigella sp. or other closely related organisms 
(Enterobacteria phage, Salmonella typhimurium, or Klebsiella pneumoniae), were deleted. 
Predicting subcellular localisation  
Subcellular localisation was predicted using PSORTb version 3.0.2 
(http://www.psort.org/psortb/index.html). This was done by exporting all the UniProt IDs from 
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the proteins document, and using UniProt (http://www.uniprot.org/) to search for all the 
proteins. UniProt has a “Download” function, and this was used to download all amino acid 
sequence FASTA files by choosing “Download > Download all > Format: FASTA (canonical) 
> Uncompressed”. The resulting FASTA files were imported to PSORTb. 
Identifying and removing falsely detected proteins, “false positives” 
In order to identify potential false positive hits, proteins from each bacterial strain were 
considered isolated from the data from the other strains. Data from one strain did not interfere 
with data from another. Proteins from different conditions, i.e., grown in blood agar and in 
blood culture, were considered together if they were identified in the same strain. 
Visual Evaluation and Statistics to Promote Annotation (VESPA) software from Pacific 
Northwest National Laboratory (http://cbb.pnnl.gov/portal/software/vespa.html) was used. 
This software maps potential peptides, based on sequenced genomes. The aforementioned 
genome for IHE3034 was used to predict proteins for the IHE3034 strain, and the K12 genome 
MG1655 (GenBank reference: U00096.3) was used to predict proteins for the J53 strain. All 
peptides identified by MaxQuant that were not identified by VESPA in the strain in question, 
were removed from the strain’s results. In order to identify false positives in H622 - for which 
there is yet no sequenced genome - the following, more stringent, procedure was followed: 
Identification type is defined as either “By MS/MS” or “By matching”. “By MS/MS” is 
considered the strongest positive verdict for the presence of the peptide. “By matching” implies 
that there is hard MS evidence for the presence of the peptide only in one of two MS runs. The 
proteins belonging to H622 were sorted to identify the proteins where all the peptides were 
identified solely “By matching”, or which had a number of identifications “By MS/MS” of 2 or 
lower. These proteins were manually curated, and the proteins with at least two replicas 
containing identification “By MS/MS” in identification type were kept, regardless if this was 
of the same peptide in different replicas. All proteins identified only by one or none “By 
MS/MS” were removed from the H622 strain. 
Work in Perseus 
Perseus is a powerful statistical software used to quantify and analyse MS data [65]. In this 
thesis, Perseus (http://www.perseus-framework.org, versions 1.5.6.0 and 1.5.4.1) and Microsoft 
Excel has been utilized in statistical analysis of the proteomic data. When the data was handled 
in Perseus, all intensities were transformed to log2, and all replicas from one strain or condition 
– e.g, all replicas from IHE3034 in blood culture, were categorised as one group using the 
function “categorical annotation” in Perseus. For both qualitative and quantitative analysis, the 
finding of a protein was considered valid only if it were found in at least two replicas per group. 
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An analysis of variance was carried out on proteins of strains grown in clinical blood 
cultures 
In order to compare the differing expression of proteins detected in H622, IHE3034 and J53 
when grown in blood culture, an analysis of variance (ANOVA) was carried out. An ANOVA 
was chosen, as it can be used when more than two means are to be compared. The analysis was 
done in Perseus on log2-transformed LFQ intensities of 1 733 proteins shared by the three 
strains when grown in blood culture. The data from blood agar was not considered. Mode of 
ANOVA was permutation-based FDR, the number of randomizations 250, the FDR set to 0.01, 
and S0 = 0. Proteins determined valid by this test were exported to Excel, and further analysed: 
Those that had a maximum or minimum value in a replica that differed from the mean by two 
or more logarithmic units were marked as proteins of interest. 
A two-tailed t test was carried out on the strains grown on blood agar and in clinical blood 
culture 
Comparison of proteomic expression of bacteria grown in blood agar to the same strain grown 
in clinical blood culture was carried out in Perseus on proteins found in at least two replicas per 
strain. The data used was the log2-transformed LFQ intensity levels of the proteins identified in 
the strains grown on blood agar, and the log2-transformed data from the same strain grown in 
clinical blood culture. By changing only one variable – the growth conditions – and comparing 
only two components, a t-test is a valid statistical choice. A volcano plot was created using a 
two-tailed (non-paired) t test with 250 randomizations, FDR set to 0.01 and S0 = 0.1. Only 
proteins deemed significant by this test, and with levels that differed by two or more logarithmic 
units in one of the conditions were considered for inclusion in the results. 
EcoCyc [88], DAVID [89], and UniprotKB [90] were used in the analysis work to assign the 
proteins biochemical functions and pathways, while STRING [91] was used as a tool to 








In this section, the results from previously described experiments will be presented. 
4.1 – Phenotypic characteristics 
The phenotypic characteristics assay performed by the MID at Haukeland University Hospital 
according to their standardized protocols, yielded the following results: 
All three strains, H622, IHE3034 and J53 demonstrated the exact same pattern, typical of E. 
coli. 
Table 6 – A phenotypic characteristics assay was carried out on three strains of E. coli, 
H622, IHE3034 and J53. All strains demonstrated the same results. The results are given as 
positive (+) and negative (-). 
Trait Result Trait Result 





Acid + Urease  - 
Gas  + Indole  + 
H2S  - Lysine  + 
Mannitol fermentation + Lactose fermentation + 
 
4.2 – Multi-locus sequence typing 
E. coli strains IHE3034 and H622, both isolated from the spinal fluid of neonates, were cultured 
on blood agar plates, lysed, and a set of fragments of specific household genes were sequenced 
using predetermined primers. 
The resulting sequences indicate that H622 belongs to ST 421, and IHE3034 belongs to ST 95. 
Both strains belong to ST Complex 95 (Table 7). The sequences in their entirety, can be found 
in supplementary materials. 
 
Table 7 - MLST results for H622 and IHE3034. 
Strain Adk FumC GyrB Icd Mdh PurA RecA ST ST 
Complex 
H622 37 38 19 37 17 8 26 ST 421 ST 95 
Complex 










The bacterial strains H622, IHE3034 and J53 were tested for the presence of four genes 
(Figure 1). H622 and IHE3034 show an identical pattern: arpA(-), chuA(+), yja.A(+), 
TspE4.C2(+). (- + + +). The K12 derivative J53 demonstrates the following pattern: arpA(+), 
chuA(-), yja.A(+), TspE4.C2(-). (+ - + -). According to Clermont et.al. [21], this indicates that 
the NMEC strains belong to group B2, and J53 to group A. 
 
4.4 – Antibiotic susceptibility 
The bacterial strains H622, IHE3034 and J53 were tested with a number of antibiotics (Table 
8). The quality control ATCC 25922 was within the ranges established by EUCAST [92]. 
 Only H622 demonstrated resistance towards any of the tested antimicrobials. According to 
clinical breakpoint tables for bacteria v.7.1 developed by EUCAST, H622 was resistant towards 
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   –  100 bp 
Figure 1 - Phylogenetic grouping results of H622(- + + +), IHE3034(- + + +) and 




Table 8 – Results of antibiotic susceptibility testing. Strip results are given in MIC, Zone 
indicates mm diameter of zone of inhibition around the antibiotics disc. Only H622 exhibits 
any resistance. “Strip” indicates MIC number, as read on the test strip, given in µg/ml. 
“Zone” indicates the diameter of the zone of inhibition, in millimetres. Clinical breakpoints 
are given. S = sensitive, R = resistant. N/A = not applicable here. 
Antibiotic ATCC 
25922 
























































































clavulanate   
Zone: 21 19 23 22 N/A N/A 19 19 
Ceftazidime  Zone: 25 27 27 28 N/A N/A 22 19 
Cefuroxime  Zone: 22 24 24 23 N/A N/A 19 19 
Ertapenem Zone: 33 34 36 38 N/A N/A 19 19 
Imipenem  Zone: 31 29 28 31 N/A N/A 20 17 
Meropenem  Zone: 33 33 35 34 N/A N/A 22 16 
Piperacillin-
tazobactam 
Zone: 24 24 25 27 N/A N/A 20 17 
Trimethoprim-
sulfamethoxazole 











Bacterial strains H622, IHE3034 and J53 were 
lysed, their DNA digested using endonucleases, and 
run on a PFGE. The resulting gel (Figure 2) shows 
that H622 contains a large plasmid with a size 
between 100 and 150 kilobase (kb). IHE3034 and 









4.6 – Presence of small plasmids 
DNA was extracted from H622 and BL21(DE3)pLysS and digested using a S1 endonuclease.  
The agarose gel (Figure 3) shows that H622 has no genetic elements smaller than 15 kb. 
BL21(DE3)pLysS has a large amount of DNA at ~5 kb, and smaller amounts at 6 kb, 9 kb and 


















 Figure 2 – PFGE results of J53, H622 
and IHE3034. H622 demonstrates the 
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Figure 3 – DNA from H622 and BL21(DE3)pLysS digested with nuclease and 
run on an agarose gel electrophoresis. BL21(DE3)pLysS shows DNA at ~5kb, 
6 kb, 9 kb and 15 kb. H622 has no genetic material below 15 kb. The negative 




4.7 – Mass spectrometry results of bacteria grown in blood cultures and blood 
agar 
Quantitative protein profiles of E. coli strains H622, IHE3034 and J53 were created using 
MS/MS. The bacteria were grown in clinical blood cultures, lysed and digested with 
proteinases, before being analysed using LC-MS/MS. Data from an earlier experiment in the 
same lab using the same method and the strains IHE3034 and J53 grown on blood agar were 
included in the analysis of MaxQuant raw spectra. The quantification technology MaxLFQ, 
integrated in the MaxQuant analysis platform, was used to normalize and quantify all proteins. 
The quantitated data is used for all statistical and quantitative analysis, such as comparison of 
protein levels between strains and conditions. In order to aid analysis, all LFQ values were 
transformed to log2 before analysed statistically or included in figures.  
In order to assess the correlation of all replicas within one strain, several multi scatter plots 
were created in Perseus, comparing replicas within one strain to each other. This was carried 
out on the intensity values, and the LFQ intensities. For the normalized LFQ spectra, the 
Pearson correlation coefficient R varied from smallest 0.988 to largest 0.995 (Table S7 in 
supplementary materials). This establishes the similarity between replicas. A box plot was 
created to compare the distribution of LFQ levels of all proteins across strains (Supplementary 
materials, Figure S2). Both the scatter plots and the box plot shows a uniform distribution of 
LFQ intensities across strains.  
There were 103 proteins identified by only one peptide, they can be found in supplementary 
materials Table S9, along with the peptide sequence and detailed information about the MS/MS 
spectrum. Proteins that shared peptides, potentially making the LFQ intensities too high or too 
low per protein, can be found in supplementary materials Table S8. Potential detected isoforms 
of proteins can be found in supplementary materials Table S10, along with alignments of the 
amino acid sequences.  
A total of 31 785 peptides representing 2 707 proteins were detected when analysing all strains 
and growth conditions, with an average per strain of 2260 identified proteins (Table S2 and 
Table S1 in supplementary materials). The dynamic range covers proteins of LFQ intensity 
from smallest 215.3 to largest 234.5. This signifies a fold difference where the most abundant 
proteins are observed more than 600 000 times as often as the least abundant. Four of the 
proteins that were detected did not possess high enough intensity levels to be included in the 
quantitated LFQ intensities. 
As an example of a detected peptide with a good score, Figure 4 shows a tandem mass spectrum 




MaxQuant. The fragments of the peptide can be seen as peaks along the x-axis, which represents 
m/z ratio. For the entire peptide, m/z=360.86, score=89.89 The y-axis represents relative 
abundance, with the highest peak at m/z= 376.22 set at 100 %, and the other peaks are given in 








Figure 4 – Tandem mass spectrum of a peptide as seen in the viewer of MaxQuant. The y-axis 
represents relative abundance, and the highest peak has been assigned 100%. Mass to charge 
ratio, m/z is represented by the x-axis. This peptide has been identified as having the sequence 





4.7.1 – Detection of proteins using LC-MS/MS analysis 
 
Figure 5 – Venn diagram illustrating the number of 
shared proteins detected between E. coli strains H622, 
IHE3034 and J53 when grown in clinical blood cultures. 
Numbers in parentheses signify the total number of 
proteins detected within the strain. Numbers in italic 
describe the unique proteins found only in the specific 
strain under these conditions. This is purely the detected 
proteins, and do not reflect the expressed levels of 
proteins.  
  
A total of 1 877 proteins were detected in all strains, H622, IHE3034 and J53, when grown in 
clinical blood culture (Figure 5). When considering all strains and growth conditions, clinical 
blood culture and blood agar, 1730 proteins were found to be in common.  
The shared proteins detected consist of the larger part of the bacteria’s cellular machinery, 
needed for metabolism and replication. Many are found at similar levels, and do not vary 
significantly between strains. Proteins worth mentioning are AtpABCDEFGH (Figure 6), 
subunits of ATP synthase, DnaABEGJKNX, proteins considered necessary for binding to oriC 
and initiating and sustaining DNA replication, and RpsABCDEFGHIJKLMNOPQRSTU, 
ribosomal proteins S1-21 of the 30S ribosomal subunit  [94-104]. The proteins of interest that 
will be discussed in this thesis are the ones that varied significantly between, or were detected 


















Prediction of cellular localization of proteins 
A prediction of subcellular localization was carried out using PSORTb to determine the 
coverage and detection of proteins from different subcellular locations. PSORTb uses the 
FASTA sequence of proteins to give an estimation of where in the cell the proteins were likely 
to have been found. Strains IHE3034 and J53 have been sequenced and annotated, and their 
predicted proteomes were found in UniProt Proteome and downloaded from UniParc. The 
protein FASTA sequences were analysed in PSORTb to find the predicted subcellular location 
[20, 69, 105, 106]. All proteins with the predicted subcellular localization can be found in 
supplementary materials, Table S3. 
Using PSORTb, the cellular localization of identified proteins was predicted bioinformatically 
(Table 9). The approximate coverage of proteins from different compartments was very similar 
across strains. The annotated genomes were analysed using PSORTb in the same way, and the 
resulting numbers used to determine how much of a certain group of proteins had been detected 
in the analysed strains. Approximately 50 % of annotated proteins of E. coli strains IHE3034 
and J53 grown in clinical blood culture were detected. 
 
Table 9 – PSORTb was used to predict the subcellular localization of detected proteins in 
strains grown in clinical blood cultures. The detected proteins were compared to sequenced 
Figure 6 – Quantitative profiles of differentially expressed proteins belonging to E. coli 
strains H622, IHE3034 and J53 grown in clinical blood cultures and analysed using LC-
MS/MS. All error bars are ± one standard deviation of the mean. Subunits of ATP synthase 




and annotated genomes of IHE3034 and J53. “Number observed” indicates the number of 
detected proteins, sorted by PSORTb prediction. “Percent of annotated” describes how large 
percentage the detected proteins have covered of the annotated proteins. * The genome of 
H622 has not been sequenced. 











Cytoplasmic 1246 - * 1358 71.32% 1346 65.24% 
Cytoplasmic 
membrane 




Extracellular 11 - 14 30.43% 9 15.79% 
Outer membrane 49 - 49 51.04% 51 50.50% 
Periplasmic 104 - 113 68.90% 110 67.07% 
Unknown 264 - 336 26.88% 314 25.12% 







4.7.2 – Quantitative analysis of proteins detected in LC-MS/MS analysis using 
normalized LFQ intensities 
All statistical analysis of the proteins and comparison of protein levels between strains was 
carried out using the LFQ intensity levels. All LFQ levels shown have been log2-transformed. 
Here, the strains will be generally compared and considered, before the analysis and results of 
differing protein levels are described. Statistical methods have been used to detect statistically 
significant variation between detected levels of proteins. 
Correlation between biological replicas 
Each strain was grown in two clinical blood culture bottles designated “A” and “B”. The 
average between these biological replicas have been used when analysing and comparing 
strains, therefore a comparison of the biological replicas themselves was warranted. Figure 7 
shows multi scatter plots of, and the correlation between, the LFQ intensities of the proteins in 
the biological replicas. E. coli H622 has the highest correlation between blood cultures of the 
three strains with a Pearson correlation coefficient R of 0.998 (Figure 7A). For the strains 
IHE3034 and J53, the Pearson correlation coefficients are 0.993 and 0.996, respectively (Figure 





Variation between biological replicas 
The correlation coefficient R between the biological replicas is at, or higher than, 0.993 for all 
three strains, and at the same time, the variation between the values of proteins found in both 
of the biological replicas is less than 0.3 % on average for the three strains grown in blood 
culture. The variation was found by determining the distance between the values per protein, 
and divide that value by the average value of the protein (Equation (1)). “A” and “B” refers to 
the values of each protein in the respective clinical blood cultures. All values used were the 





 × 100 % 
Figure 7 – E. coli strains H622 (A), IHE3034 (B), and J53 (C) were grown in 
clinical blood cultures, two blood culture bottles per strains. These biological 
replicas were compared in scatter plots using their log2-transformed LFQ 
intensities. Numbers in blue describe the Pearson correlation coefficient R.  





    








J53 is used as an example, values and tendencies are representative for all three strains (Figure 
8, Figure 9).  
 
Figure 8 shows a frequency distribution of the variation between LFQ values of proteins found 
in both of the biological replicas. The distribution shows how accurate the quantitative data are. 
It demonstrates that the great majority of the proteins exhibited LFQ values that varied less than 
0.2 % between blood cultures. 
 
Figure 8 – Histogram showing the frequency distribution of variation between protein 
values in the biological replicas (blood cultures) of J53, given in percent. The majority of 
the proteins exhibit a variation of less than 0.2 % from the average value of the protein. 
 
Equation (1) – Determining the variation between LFQ values of the 





The same numbers used for Figure 8 were employed in Figure 9, where a scatter plot was 
created to visualize the correlation between log2 LFQ intensities and variation between the 
biological replicas. In general, most of the data points exhibit very low variation between the 
replicas, and the variation becomes lower with increasing LFQ. The largest difference between 
data points in the replicas is seen at lower LFQ intensity. The example shown uses values from 
E. coli strain J53, but is representative for all strains grown in blood culture. The most abundant 
proteins are more accurately quantified than the least abundant proteins. 
Frequency distribution of protein levels and correlation between strains 
Before the detailed comparison of protein levels across strains will be presented, the distribution 
of LFQ intensities per strain is shown. These figures describe the distribution of LFQ intensity 
levels found in the strains. Figure 10 shows the distribution of log2-transformed LFQ levels by 
frequency. All strains grown in clinical blood are relatively similar, with the majority of proteins 
detected having a log2 LFQ intensity between 22 and 28 (Figure 10). The curve slopes evenly 
towards the higher numbers on the right, and somewhat more sharply towards the lower 
frequencies on the left.  
 
Figure 9 – The variation between blood cultures was determined and plotted 





As the distribution of LFQ levels was established within strains, further comparison of the three 
strains was carried out, by creating a multi scatter plot and finding the Pearson correlation 
between all strains. Figure 11 shows multi scatter plots comparing all strains grown in clinical 
blood culture using log2-transformed LFQ levels of proteins. The Pearson correlation 
coefficient per scatter plot is shown in blue. The correlation between H622 and IHE3034 was 
Figure 10 – Three strains of E. coli, A) H622, B) IHE3034 and C) J53, were grown in clinical 
blood culture, and their proteins analysed via LC-MS/MS. The histograms show the 




















the highest, with a correlation of 0.944 (Figure 11 A). The lowest correlation could be seen 
between J53 and IHE3034, with a Pearson correlation coefficient of 0.868 (Figure 11 C). 






Figure 11 – A multi scatter plot comparing log2-transformed LFQ 
intensities for strains H622 (H), IHE3034 (I), and J53 (J). 
Numbers in blue describe the Pearson correlation between 
strains. LFQ intensity is log2-transformed. 





                                        






Results from ANOVA analysis of strains grown in clinical blood culture 
In order to compare the strains H622, IHE3034 and J53 when grown in clinical blood cultures, 
an ANOVA was carried out using Perseus and the results analysed using Excel. The ANOVA 
of the log2-transformed LFQ spectra resulted in the finding of 79 proteins. These were the 
proteins that were found in all three strains and determined as significant by the Perseus 
ANOVA, while also having LFQ intensities in at least one replica that varied from the mean by 
more than two logarithmic units. I.e., LFQ intensities in one or more replicas that were four 
times as high as, or a quarter of, the mean (Table S4 in supplementary materials). In the 
following section, proteins found to differ by more than this, or not detected in all strains, will 
be presented. All figures are equipped with error bars representing ± one standard deviation. In 
many figures, the error bars are so short that they become obscured by the marker. 
4.7.2.1 – Proteins upregulated in the NMEC strains when grown in clinical blood 
cultures 
The aims of this work include comparing the protein expression levels between the E. coli 
strains H622, IHE3034 and J53 when grown in clinical blood culture. The resulting MS data 
were analysed statistically, and some of these results are presented here.  
In this section, proteins that were deemed significant by the ANOVA analysis of shared proteins 
between H622, IHE3034 and J53, and/or were detected only in the NMEC strains are presented. 
The proteins are categorized by their functions as deemed by current research, along with a 
brief description. This entails the following groups of proteins:  
1. Proteins detected in all strains when grown in clinical blood cultures and found to have 
LFQ intensities more than two logarithmic units above the mean in either H622, 
IHE3034, or both. 
2. Proteins that were detected in only one or both of the NMEC strains when grown in 























Figure 12 – Quantitative profiles of differentially expressed proteins belonging to E. coli 
strains H622, IHE3034 and J53 grown in clinical blood cultures. All error bars are ± one 
standard deviation of the mean. Names with (*) designate proteins present in all three strains 
that varied by more than two logarithmic units from the mean. If unmarked and detected in all 
three strains, the proteins were deemed significant by the ANOVA analysis in Perseus. A) 
Proteins Che, Tar and Tsr, thought to be involved in chemotaxis, and proteins NanAEK, 
responsible for degradation of sialic acid were detected at higher level in strains H622 and 
IHE3034, when compared to J53. NanR, marked with ¤ , was not deemed significant by the 
ANOVA analysis. B) The same pattern could be observed in detected Flg and Fli proteins, 





Degradation of sialic acid has been proposed to be mediated by the proteins NanAEK, and 
repressed by NanR [107, 108]. In the two NMEC strains, NanAK was found at similar levels, 
markedly elevated compared to the data from J53 (Figure 12A). NanE, while more similar 
across strains, was found at slightly higher levels, and the variation was considered significant 
by the ANOVA analysis done in Perseus. The repressor NanR was not considered statistically 
significant in Perseus, and is detected in almost identical abundance in all three strains grown 
in blood culture. 
Motility and chemotaxis 
The protein machinery involved in motility, such as flagellum- and chemotaxis-associated 
proteins were found expressed to a larger degree in the pathogenic strains (Figure 12B). Some 
of these proteins were below the detection limit in J53. According to van Albada et al. and 
Cardozo et al., the complex CheABRWYZ work together to transmit signals from methyl-
accepting chemoreceptors Tar and Tsr to the flagellar machinery [109, 110]. Tar and Tsr both 
sense amino acids, and have especially high affinity for aspartate and serine, respectively [111]. 
Notably, these proteins follow a similar pattern; H622 and IHE3034 are close together, and J53 
slightly lower. The proportional distance between the protein levels across strains is similar for 
several of these proteins. 
 As for flagellar proteins, these data depicted a clear tendency, although the exact levels of 
quantitated protein varied (Figure 12B). Proteins that are purported to be involved in creating a 
functional flagellar motor were expressed at overwhelmingly higher levels in H622 and 
IHE3034. FlgE, FliFIMS, and FlhA could only be detected only in the NMECs. While present 
in J53, FlgH and FliCG were found in higher levels in H622 and IHE3034. FlgKLMN and 
FliDLP were not found in H622 or J53 when considering LFQ values. These proteins, apart 
from FlgM, are considered parts of the flagellar motor, the filament, or movement and assembly 
of these [112]. Experimental evidence suggests that FlgM participates in the regulation of gene 
expression of the aforementioned proteins in Salmonella typhimurium [113]. In general, the 
NMEC strains exhibit similar levels, with IHE3034 slightly above H622. All proteins of the 
NMEC strains in Figure 12 AB demonstrate a shorter standard deviation than their counterpart 
in J53.   
Nucleotide metabolism 
Turnbough et al. suggest that PyrE, orotate phosphoribosyltransferase, catalyzes de novo 




NMEC strains than in the K12 (Figure 13) [114]. The protein was found in similar abundance 
in both IHE3034 and H622. 
 
Amino acid metabolism 
PutA is thought to be a bifunctional membrane-associated protein that catalyses the oxidation 
of L-proline to glutamate. It may also function as a transcriptional repressor of other put genes 
when proline is sufficiently available [115]. This protein is detected at lower levels in J53, with 
IHE3034 expressing the most (Figure 13). Compared to PyrE, the NMEC strains are further 
apart, and not as similar in their expression of the protein. 
Capsular polysialic acid synthesis 
Capsule synthesis proteins showed very different expression in the three strains. Synthesis of 
capsular polysialic acid NeuNAc(α2-8), is orchestrated by gene clusters neu and kps [116, 117]. 
For the pathogenic strains, proteins NeuABCDES and KpsCDEFMU were detected on similar 
levels, while not detected at all in J53 (Figure 14). KpsT was only seen in H622. These genes 
are all essential in creating the polysialic acid capsule seen in E. coli exhibiting K1 capsular 
antigen [47, 118]. Both NMEC strains express the proteins at very similar levels, almost 





Figure 13 – Quantitative profiles of differentially expressed 
proteins belonging to E. coli strains H622, IHE3034 and J53 
grown in clinical blood cultures. All error bars are ± one 
standard deviation of the mean. Names with (*) designate 
proteins present in all three strains that varied by more than 
two logarithmic units from the mean. Proteins PyrE and 
PutA are considered important in nucleotide and amino acid 







A similar pattern could be seen for proteins of the bcs operon, which are thought to be involved 
in the synthesis of bacterial cellulose, and important for the formation of biofilms [119, 120]. 
Proteins BcsBCEQZ were significantly elevated, or detected solely in H622 and IHE3034 
(Figure 15). BcsAG could only be detected in IHE3034. The majority of these proteins, 
especially in the NMEC strains, varied very little, and possess low standard deviations.   
 
Figure 14 – Quantitative profiles of differentially expressed proteins belonging to E. coli 
strains H622 and IHE3034 grown in clinical blood cultures show high levels of kps and 
neu proteins. All error bars are ± one standard deviation of the mean. The figure portrays 







Iron acquisition and iron-related virulence 
ChuAST, alleged receptor and oxygenase for the utilization of heme, were present in high levels 
in H622 and IHE3034, while not being detected in J53 [49, 121] (Figure 15). IroCN, considered 
important in uptake and excretion of iron chelating siderophores, were detected at higher levels 
in the NMEC strains, with iroC not detected in J53 [122, 123]. The ChuA protein in IHE3034 
and IroN protein in J53 possessed slightly higher standard deviations due to a larger difference 
between the biological replicas. Outer membrane protein OmpW is a β-barrel membrane protein 
with a hydrophobic channel whose expression is regulated by iron. It has been tentatively 
suggested to be involved in iron uptake, and postulated to be involved in iron-related virulence 
[124, 125].  
Figure 15 – Quantitative profiles of differentially expressed proteins belonging to E. coli 
strains H622, IHE3034 and J53 grown in clinical blood cultures. All error bars are ± one 
standard deviation of the mean. Names with (*) designate proteins present in all three 
strains that varied by more than two logarithmic units from the mean. If unmarked and 
detected in all three strains, the proteins were deemed significant by the ANOVA analysis 
in Perseus. The three E. coli strains demonstrated very different levels of protein 
expression. Proteins BcsABCEGQZ, functional in cellulose biosynthesis, were detected at 
higher levels in H622 and IHE3034 than J53. Some proteins (BcsAEG) were not above the 
detection limit in J53. Proteins ChuAST, IroCN and OmpW, deemed important in iron 
acquisition, were also seen at higher levels in the NMEC strains, with three proteins 
(ChuAT and IroC) not above the detection limit in J53. Small heat shock proteins IbpAB 
were also seen differing in levels; IbpA exhibited a lower LFQ intensity in J53 than in the 




Stress response  
Small heat shock proteins IbpAB were more expressed in the NMEC strains (Figure 15). These 
proteins are thought to bind to and stabilize unfolded proteins, readying them for refolding 
[126]. Despite IbpB not being found in J53, there is little similarity in the expression levels 





4.7.2.2 – Proteins expressed at a higher level in J53 than in H622 and IHE3034 when 
grown in clinical blood cultures 
In this section, proteins that were detected at higher levels in the LFQ intensities of J53, 
compared with those of NMEC strains H622 and IHE3034, will be presented. The proteins are 
categorised by their functions as deemed by current research, along with a brief description.  
While J53 displayed a decidedly lower level of expression of virulence factors, it differed from 
IHE3034 and H622 in its level of expression of several metabolically related proteins. 
This entails the following groups of proteins:  
1. Proteins detected in all strains when grown in clinical blood cultures and found to 
have LFQ intensities of more than two logarithmic units above the mean in J53. 







Peptide and amino acid transport 
Proteins OppABCDF are regarded as vital for creating the Opp transporter for oligopeptides, 
and DppABCDF as a mediator in dipeptide transport [127, 128]. Apart from OppD, these were 
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Figure 16 – Quantitative profiles of differentially expressed proteins belonging to E. coli 
strains H622, IHE3034 and J53 grown in clinical blood cultures. All error bars are ± one 
standard deviation of the mean. Names with (*) designate proteins present in all three 
strains that varied by more than two logarithmic units from the mean. If unmarked and 
detected in all three strains, the proteins were deemed significant by the ANOVA analysis 
in Perseus. J53 exhibited a higher expression of A) proteins involved in peptide and amino 
acid transport, and B) members of the trp regulon, responsible for biosynthesis of L-
tryptophan, along with proteins important for amino acid metabolism, DadAX, TnaA, 




all decidedly higher in, or solely detected in J53 (Figure 16B). The biological replicas expressed 
very similar levels, as seen by the very small standard deviations. Experimental evidence 
suggests that DppABCDF can function as a heme permease [129].  
Other amino acid transport proteins could be observed at a higher expression level in J53 as 
well: Mtr, and SdaC, responsible for tryptophan and L-serine transport, respectively [130, 131]. 
SdaC differs from the other proteins presented in this paragraph, as IHE3034 expresses a similar 
level of the protein, and H622 is seen with an expression level lower than the other two. 
Amino acid metabolism 
Members of the trp regulon TrpABCE are considered important components of the biosynthesis 
of L-tryptophan [132, 133]. Proteins of this regulon all followed the same pattern, but only 
TrpCE differed from the mean by more than two logarithmic units. These are also the only Trp-
proteins where J53 is markedly higher in its expression than the NMEC strains. TrpAB, while 
considered significant by the Perseus analysis, are expressed more similarly across strains than 
TrpCD. TrpGD was not detected in the LFQ intensities of IHE3034, while TrpR, the 
transcriptional repressor of the trp regulon, and the tryptophan-tRNA ligase TrpS were found 
at very similar levels across strains (Figure 16B). DadA, important for alanine degradation, and 
DadX, an alanine racemase thought to catalyse the conversion between L-alanine and D-
alanine, were also detected in higher quantities in J53 [134]. Along with TnaA, which has been 
suggested to degrade tryptophan to ammonia, pyruvate and indole [135]. Proteins considered 
important in glutamine and glutamate metabolism, GlsA1, a glutaminase, and GdhA, a 
glutamate dehydrogenase, could also be observed at higher levels of expression in J53 [136, 
137]. GlsA1 differs from GdhA by being similarly expressed in J53 and H622, while GdhA 







The purported multidrug efflux pump EmrAB demonstrated significant elevation, while its 
repressor, MprA, was below the limit for inclusion within LFQ data in J53 (Figure 17) [138, 
139].  
Iron acquisition 
While OmpW was seen at much higher levels in H622 and IHE3034 (Figure 15), J53 
demonstrated a significant upregulation of siderophore uptake receptors CirA and Fiu (Figure 
17). These proteins are thought to be able to compensate for a lower expression of OmpW  [125, 
140].  
Carbohydrate metabolism 
The Gat proteins were either exclusively expressed in J53, or at a significantly higher level. 
Experimental evidence suggests that proteins GatABDYZ all participate in the transport and 
Figure 17 – Quantitative profiles of differentially expressed proteins belonging to E. coli 
strains H622, IHE3034 and J53 grown in clinical blood cultures. All error bars are ± one 
standard deviation of the mean. Names with (*) designate proteins present in all three 
strains that varied by more than two logarithmic units from the mean. If unmarked and 
detected in all three strains, the proteins were deemed significant by the ANOVA analysis in 
Perseus. Proteins EmrAB, responsible for drug efflux and its repressor MprA are both 
expressed higher in J53. Proteins CirA and Fiu, important in iron acquisition are expressed 
higher in J53 than in the NMEC strains. Galactitol metabolism proteins of the gat operon are 
detected almost solely in J53, apart from the repressor GatR, which is not seen in J53. Suf 





degradation of the sugar alcohol galactitol. GatR stood out from the rest by being undetected 
in J53, and at a similar level in the other two strains (Figure 17). GatR is considered a 
negative regulator of the gat operon  [141] .  
Iron-sulfur cluster assembly 
The SufABCDS proteins involved in iron-sulfur cluster assembly were very differently 
expressed between the NMEC strains. They were elevated in H622, while being lower in 
IHE3034 than both other strains (Figure 17). SufA was only detected in H622 and J53, when 
considering LFQ values. This differs from the other patterns of expression levels presented 
here, by the NMEC strains not sharing similar expression levels, and serves as an example of 







4.7.2.3 – Analysis of IHE3034 and J53 cultured under different conditions 
Two E. coli strains, the NMEC strain IHE3034 and the K12 commensal strain derivative J53 
were grown on blood agar plates and in clinical blood cultures, before being enzymatically 
digested and analysed using LC-MS/MS, and subsequently analysed computationally. The 
culturing of bacteria on blood agar plates was done in an earlier experiment in the Gade 
Research Group for Infection and Immunity, and the raw data included in this thesis.  
 
Effect of different culture conditions on proteomic expression in IHE3034 and J53 
In order to assess the correlation between the strains when grown under different conditions, 
two scatter plots were created using the proteomic data in Perseus (Figure 18). When comparing 
IHE3034 grown in clinical blood culture to itself when grown on blood agar, the Pearson 
correlation coefficient was 0.739. The K12 strain J53 had a similar correlation coefficient, with 
0.725. Both strains showed an even distribution of differences in proteomic expression across 
LFQ intensities.  
 
 
In order to detect the proteins that differed the most between the two conditions, the data were 
analysed statistically using the program Perseus. The different conditions were compared by 










Figure 18 – E. coli strains IHE3034 (A) and J53 (B) were grown in 
clinical blood culture and on blood agar plates, before being analysed 
using LC-MS/MS. Scatter plots were created in order to compare 
quantitative protein profiles across culture conditions. LFQ intensities are 
log2-transformed. 
      A              B 
 




a FDR of 0.01 using the program Perseus (Figure 19). Between IHE3034 grown in blood culture 
and on blood agar, 1 388 proteins were found to have a significant difference in LFQ intensity 
levels. Of these, 270 proteins differed in LFQ intensities between conditions by more than two 
logarithmic units, i.e., more than four times as much in one condition than in the other. The 
same numbers for J53 are 1 326 and 268, respectively (Table S5 and Table S6 in supplementary 




The two strains shared several common traits in up- and downregulation of certain pathways 
and operons when grown in clinical blood culture, compared to being grown on blood agar. 
Figure 19 – E. coli strains IHE3034 and J53 were grown in clinical blood culture, and  
on blood agar, before being enzymatically digested and analysed using LC-MS/MS. A 
two-tailed t test with 250 permutations an FDR of 0.01, and s0 of 0.1 was used to detect 
proteins that differed in expression between growth conditions within the same strain. The 
volcano plots illustrate the logarithmic fold change (x-axis) and the negative logarithm of 
the p-value (y-axis) of plotted proteins. Blue squares illustrate proteins that differed 
between conditions by more than two logarithmic units. 
A: In IHE3034, 270 proteins were detected that differed in expression levels between 
growth conditions by more than two logarithmic units.  B: In J53, 268 proteins that 
differed in expression levels between growth conditions by more than two logarithmic 
units were detected. 
 







Yet, a number of proteins could only be detected as to differ by more than two logarithmic units 
between conditions in one of the strains, not both. 
The two strains shared the following changes in certain proteins: 
In the following paragraphs, a selection of the proteins that follow a similar expression pattern 
between conditions in both strains is presented. 
Proteins that were higher expressed in strains grown on blood agar 
Carbohydrate metabolism 
When grown on blood agar, both strains saw a higher expression of proteins purported to be 
involved in the utilization of different carbon sources: AceAB, AcnAB, Acs, GlcBCEG, GltA, 
and Mdh are proteins thought to be involved in the metabolism of isocitrate, citrate and malate. 
These enzymes are considered important constituents of the glyoxylate cycle, responsible for 
enabling the bacterium in using acetyl-CoA as a carbon source [142]. The glyoxylate cycle is 
closely tied to the tricarboxylic acid (TCA) cycle, and share enzymes such as isocitrate 
dehydrogenase, Icd. When analysed, this catabolic pathway followed the same pattern as the 
enzymes of the glyoxylate cycle, and saw significantly higher intensities in the bacteria grown 
on blood agar compared to the ones harvested from blood cultures. Important proteins of the 
prokaryotic TCA cycle I that were found to be significantly elevated on blood agar were 
SdhABCD, subunits of succinate dehydrogenase enzyme, SucAB, subunits of 2-oxoglutarate 
dehydrogenase complex, and SucCD, succinyl-CoA synthetase [143, 144]. FbaB, active in 
gluconeogenesis, was more expressed in the samples from blood agar than the ones grown in 
liquid blood culture [145]. However, not all proteins of carbohydrate metabolism were varied 
in this way. FruABK, proteins regarded as important for fructose catabolism and transport, 
could be detected at much lower intensities in the strains when grown on blood agar plates than 
in blood culture [146].  
Fatty acid metabolism 
FadADL, proteins that are widely accepted as catalysing β-oxidation and transporting fatty 
acids, were detected at lower levels in the strains grown in clinical blood culture [147-149]. 
Amino acid metabolism and transport 
As with carbohydrate metabolism, amino acid transport proteins were detected at higher levels 
in blood agar-grown bacteria. Argt, a probable transporter of L-ornithine, L-arginine, and L-
lysine, and Glnh, a L-glutamine transporter, could all be seen at higher expression levels when 
grown on blood agar [150]. Other proteins that were seen at a higher intensity in blood agar-
grown bacteria include PutAP, catalysing proline degradation and transport, and Csta, a peptide 




Bacterial electron chain transport 
CyoAB, subunits of bacterial ubiquinol oxidase were seen at elevated expression levels in 
bacteria grown on blood agar [153]. 
Osmotic stress 
Experimental evidence has demonstrated increased expression of OsmBCEY when bacteria 
have been exposed to osmotic stress [154-157]. These proteins were seen in higher levels when 
the bacteria were grown on blood agar. As were ProVWX, constituents of an osmosensitive 
transport system for glycine betaine and proline betaine [158].  
Proteins that were higher expressed in strains grown in clinical blood culture 
Chemotaxis 
Both strains demonstrated an upregulation of chemotaxis protein CheA in the blood culture 
grown bacteria. The strains differed in expression of CheY: in J53, it was expressed higher in 
the bacteria grown on blood agar, whereas IHE3034 showed high levels of both chemotaxis 
proteins in the clinical blood culture. 
Nucleotide biosynthesis 
The proteins PurCEHLMT, important enzymes in purine biosynthesis, were more expressed in 
the bacteria grown in blood culture [159].  
Ribosomal proteins 
J53 only had one 50S ribosomal protein at elevated levels in the blood culture-grown bacteria, 
RpmH, while IHE3034 showed significantly higher levels of RplBDMNOPQSTVX and 
RpmABCDFGH in the clinical blood culture.  
4.7.2.4 – Other MS results 
When the MS results were examined for presence of β-lactamase, two enzymes were found: β-
lactamase, gene name ampC, and β-lactamase TEM, gene name bla. Bla is found only in H622 
grown in clinical blood culture (Figure 20). This enzyme is a class A β-lactamase, which can 
often be inhibited by small molecule inhibitors like clavulanic acid and tazobactam [160, 161]. 
AmpC was seen in IHE3034 and J53, in blood culture and when grown on blood agar (Figure 







Figure 20 – Quantitative profiles of differentially 
expressed proteins belonging to E. coli strains 
H622, IHE3034 and J53 grown in clinical blood 
culture and on blood agar. “BA” designates 
grown on blood agar. All error bars are ± one 
standard deviation of the mean. AmpC is only 
quantitated in J53 in clinical blood culture and on 
blood agar, as well as IHE3034 on blood agar. 






Bacterial meningitis in infants is a potentially debilitating disease with a 15 % mortality rate 
and the potential of serious neurological sequelae. E. coli is a common bacterial cause of this 
infection, and the incidence of E. coli meningitis in an industrialized country has been estimated 
to 0.04 cases out of 1000 live births. In this work, three E. coli strains, H622, IHE3034 and J53, 
two of which were isolated from the spinal fluid of a neonate, were cultivated in clinical blood 
culture before being lysed, enzymatically digested and analysed using LC-MS/MS. 
Quantitative protein profiles were created for all three, and the quantitated protein expression 
compared for differences in relative protein levels between the strains. Before the LC-MS/MS 
analysis, several tests were carried out in order to characterise the E. coli strains genetically and 
biochemically. 
5.1 – Phenotypic characterisation and genetic analysis 
An investigation of phenotypic expression was carried out at Haukeland University Hospital 
following their standardized protocols. All strains shared the same results, results which are 
typical for E. coli. This establishes that the strains are very similar in expressing proteins 
involved in the pathways that were tested for here. 
The MLST was carried out on the NMEC strains. They are both members of the same ST 
complex; ST complex 95. IHE3034 has been classified as ST 95 earlier, so this test confirms 
the earlier results [20]. This indicates that H622 and IHE3034 are closely related. There exist 
23 ST complexes, which are groups of closely related STs. Each ST complex “includes at least 
three STs that differ from their nearest neighbour by no more than two of the seven loci” [71]. 
Wirth et.al. investigated 462 E. coli isolates from around the world, and found that ST complex 
95 includes ST types from K1 strains and enteropathogenic E. coli (EPEC). In fact, several 
different pathotypes shared ST complex groups, and similar genetic traits. It has been postulated 
that closely related pathogenic E. coli such as EPEC and enterohaemorrhagic E. coli (EHEC) 
are able to change pathotype through the acquisition or loss of very few genes [71]. 
The strains were assigned to phylogroups through the use of the quadruplex phylo-typing 
method. Moriel et al. classified IHE3034 as a B2, and our results reaffirms that [20]. These 
results are in tune with research performed earlier, as NMEC strains usually belong to the 
phylogroup B2, and non-pathogenic strains to group A [37]. It also further establishes the close 
relations between IHE3034 and H622, and their evolutionary distance to J53. During the 
investigation of 462 strains, Wirth et.al. found that pathogenic E. coli, represented by members 




group A. They concluded that “pathogenic strains have accelerated rates of mutation and 
recombination” [71]. Pathogenic strains are subject to other evolutionary pressures than non-
pathogenic ones, including evasion of the host’s immune system. These evolutionary distances 
are reflected in the proteomic results; The multi scatter plot shows that IHE3034 and H622 are 
very similar in protein expression (Pearson correlation coefficient = 0.944). They are close to 
equal in distance to J53, with a Pearson correlation coefficient of 0.868 and 0.892, respectively 
(Figure 11).  
5.2 – Apart from H622 exhibiting resistance towards ampicillin, the strains were 
susceptible to all tested antimicrobials 
An antibiotic susceptibility assay was carried out on all three strains following standard protocol 
as established by EUCAST.  The assay determined that the only resistance shown toward the 
antimicrobials tested here, was H622. This bacterium is resistant towards ampicillin, with a 
MIC reading of > 256 µg/ml and a zone of inhibition of 6 mm (Table 8). The MIC breakpoint 
and zone of inhibition necessary to be categorised as resistant is, respectively, > 8 µg/ml and < 
14 mm. Figure S1 in supplementary materials shows that H622 was not inhibited at all by the 
ampicillin test strip. Some of the other strains are on the limit of being categorised as resistant, 
such as J53. The MIC value towards ampicillin is just within the range to be classified as 
sensitive. The zone of inhibition, however, is 19 mm, well above the 14 mm required. In the 
LC-MS/MS results, two β-lactamases were found (Figure 20). β-lactamase TEM, found in 
H622, is expressed in high enough abundancies to confer ampicillin resistance. Interestingly, 
the bacterium is sensitive towards amoxicillin and clavulanate (clavulanate is a β-lactamase 
inhibitor). As we did not test it against amoxicillin alone, it cannot be concluded that H622 is 
resistant towards amoxicillin without clavulanate. Yet, clavulanate probably inhibits the 
enzyme expressed here, as is common for this type of β-lactamase. The β-lactamase AmpC 
found in IHE3034 and J53 has not conferred resistance to these strains. Most likely, the protein 
is expressed in insufficient amounts. J53 expresses the enzyme higher than IHE3034 does, by 
about 40 percent (Figure 20, LFQ intensities of all proteins can be found in supplementary 
materials, Table S1). The difference in protein expression is enough to cause a MIC three times 
as high. Despite too low levels to successfully confer resistance, the potential for resistance is 
there, should the bacteria be exposed to β-lactam antibiotics and given the chance to express 
higher levels of the enzyme.  
Antibiotic resistance is an increasing problem in health care, and resistant pathogenic E. coli 
strains are on the rise [162]. Ampicillin resistance is not uncommon in E. coli isolates. In fact, 




infants were resistant towards ampicillin [163]. It has been speculated that the increased use of 
ampicillin during birth to reduce transmission of group B Streptococcus has contributed to this 
increase, as “the mothers of infants with ampicillin-resistant strains of E. coli were significantly 
more likely to have received intrapartum ampicillin than were those with ampicillin-sensitive 
strains” [162, 163]. However, the rate of antimicrobial resistance in NMEC strains varies, as a 
study from 2012 found the rate of ampicillin resistance in NMECs just above 20 % [164]. It is 
unknown to this thesis whether the mother of the infant from whose spinal fluid H622 was 
isolated had received ampicillin during birth. 
5.3 – H622 carries a large plasmid  
A PFGE was performed in order to examine whether H622 carries large plasmids. 
The PFGE shows that H622 carries a relatively large plasmid between 100 kb and 150 kb 
(Figure 2). Earlier research has established that IHE3034 currently does not carry any plasmids, 
which is supported here [20]. Large plasmids have been shown to increase the virulence of 
NMEC strains, and often carry virulence genes such as iron uptake systems and antibiotic 
resistance [42, 164]. It is yet unknown whether this plasmid is a carrier of the resistance genes 
contributing to the ampicillin resistance of H622. 
While it does demonstrate the presence of a large plasmid, H622 shows no signs of smaller 
plasmids. NMEC strains have not been shown to carry particularly small plasmids. Small 
plasmids may be uncommon in these bacteria, as Nicholson et al. investigated plasmids from 





5.4 – Mass spectrometry results of bacteria grown in blood cultures and blood 
agar 
The E. coli strains H622, IHE3034 and J53 were grown in clinical blood culture, lysed and 
digested by proteases before being analysed using LC-MS/MS. The resulting data was analysed 
in MaxQuant, and the detected peptides were used to identify proteins. The resulting protein 
intensity data underwent several statistical analyses and comparisons between strains. 
This part of the discussion will focus solely on the strains grown in clinical blood culture. The 
strains grown on blood agar will be discussed in section 5.4.4. 
5.4.1 – Protein detection and prediction of cellular localization of proteins 
The detection of proteins depends upon the peptides being present in high enough abundancies 
to be detected, and on correct identification by MaxQuant. More than 80 percent of the detected 
proteins are found in all three strains (Figure 5). When considering only Figure 5, it may look 
as if the NMEC strains share fewer proteins than IHE3034 and J53 does. However, if one 
considers Figure 11, it becomes clear that the NMEC strains have the highest Pearson 
correlation coefficient. This can be explained by pointing out that Figure 5 depicts only the 
detected proteins, and does not include their respective amounts.  As protein levels are included 
in Figure 11, this figure clearly shows that the NMEC strains have more in common with each 
other than either of them have in common with J53. The NMEC strains share a Pearson 
correlation coefficient of 0.944.  
The strains express proteins necessary for regular cell maintenance and replication on similar 
levels (Figure 6, all protein LFQ intensities are available in supplementary materials, Table S1). 
This demonstrates that the core genomes of these bacteria are very similar.  
PSORTb was used to predict the localization of proteins based on their FASTA sequences 
(Table 9). As the genomes of IHE3034 and J53 have been genome sequenced, it was possible 
to find their predicted proteomes in the UniProt database. The numbers for all three strains are 
relatively similar, with H622 displaying slightly fewer detected proteins overall. Fewer detected 
proteins in H622 are probably caused by the very stringent demands for filtering out false 
positives employed in this strain. The fact that the cytoplasmic proteins are the best covered in 
general is not a surprise, as they can be expected to be amongst the most abundant proteins in 
the lysate, and thus take up a large portion of the detected proteins. The proteins predicted to 
originate in the outer and cytoplasmic membranes have also been relatively well covered. 
Membrane proteins is one of the protein groups where MS has a lot higher coverage than 2DE, 
due to its ability to analyse non-soluble membrane proteins. The high coverage of proteins 




across strains. It is possible that these proteins have been “trapped” between the inner and outer 
membranes. This physical “trapping” gives an opposite effect to what may have happened to 
give such a low number – 25 percent coverage – for the detected extracellular proteins. Before 
the LC-MS/MS analysis, the bacteria are rinsed in several stages to reduce human blood 
proteins in the sample. This process has probably rinsed away a certain amount of the 
extracellular proteins. A coverage of 50 percent of predicted proteins per strain is the same level 
of coverage we have seen in earlier research, which suggests that the sensitivity of protein 
detection portrayed here is on par with earlier publications [59, 60].  
5.4.2 – Validity and reliability of biological replicas 
The quantitated proteins were first compared on the basis of correlation between biological 
replicas, the blood cultures. For all three strains grown in clinical blood cultures, the Pearson 
correlation coefficient was 0.993 or higher. Figure 7, Figure 8 and Figure 9 speak for the 
robustness of the data, showing that protein levels vary little between biological replicas. It can 
be concluded that the biological replicas are very similar. This gives credibility to the results. 
A reason for the variation at low LFQ levels can be how the MS analysis functions. The most 
abundant peptide is set as 100 % intensity, and the lower abundance peptides are set relative to 
that. Because of this, peptides from high-abundancy proteins can “drown out” peptides from 
low-abundancy proteins. This makes the exact level of low-abundancy proteins less precise, as 
well as creating a cut-off level below which the proteins are no longer detected. By looking at 
Figure 9, this limit can be established as being between 20 and 21 for the data in this thesis, 
given in log2-transformed LFQ intensities. This cut-off level and the sensitivity of the LC-
MS/MS becomes even more important when considering the frequency distribution of protein 
LFQ intensities (Figure 10). The frequency distribution appears to follow the curve of a normal 
distribution on the right side of the figure, but tapers sharply on the left. It should be pointed 
out that the sharp taper starts around 23 on the log2-transformed LFQ intensities. This is just 
above the sensitivity cut-off for of the analyses conducted here. It is very probable that the 
frequency distribution follows a normal distribution, but the proteins of lower intensities have 
not been detected due to being below the detection limit. The statistical analyses performed in 
this work are based on the assumption that the LFQ intensities follow a normal distribution. 






5.4.3 – Virulence factors are found at higher levels in the NMEC strains 
The most striking differences between the NMEC strains and J53 when grown in clinical blood 
culture, is that H622 and IHE3034 have a consistently higher expression of virulence factors. 
The phenotypic characteristics assay shows that all the strains exhibit movement (Table 6). 
Despite this, the NMEC strains express higher levels of proteins considered important for 
motility, flagella, and chemotaxis than found in J53 (Figure 12). This indicates that these strains 
are better swimmers, able to move towards sources of nutrients or other chemoattractants. 
Movement plays a vital role in the virulence of NMEC strains. By being strong swimmers in 
blood, they are less the victims of random Brownian motion. A bacterium moving purposefully 
will be more efficient in its spread and its hunt for nutrients. Here, they are grown in blood, but 
it is probable that these characteristics also help the bacteria when they are suspended in spinal 
fluid.  
An important factor connected with movement is the formation of biofilm. Wood et al. showed 
that E. coli motility was strongly correlated with its ability to form biofilms [166]. The more 
motile bacteria formed thicker biofilms with a larger coverage. Formation of biofilm is 
dependent upon the bacteria excreting extracellular polysaccharides in order to embed 
themselves in an extracellular matrix along with other bacterial cells. Not uncommonly, these 
polysaccharides include cellulose. Proteins that are members of the bcs operon are involved in 
cellulose synthesis, and experimental evidence has strongly suggested that these genes are 
necessary for E. coli biofilm formation [167]. Cellulose expression is also a factor in creation 
of the red, dry and rough (rdar) morphotype, along with the synthesis of curli fimbriae, 
controlled by genes of the csg operon [167, 168]. No Csg proteins were detected in this work. 
That does not imply they are not present, as they may be present below the detection limit. All 
this implies that the NMEC strains IHE3034 and H622 are able to move purposefully, and that 
they are proficient at forming a biofilm. Movement also plays a vital role in chemotaxis, 
something the NMEC strains strongly express proteins for (Figure 12). The ability to sense a 
chemical gradient, while being able to effectively move towards it, give these strains a strong 
advantage when colonizing a host. Both NMEC strains are especially rich in the chemoreceptors 
Tar and Tsr, which sense amino acids. These two are among the most abundant chemoreceptors 
on the surface of E. coli [169]. Tar primarily detects aspartate, asparagine, and glutamate, while 
Tsr is mainly attracted by serine, cysteine, alanine and glycine [111]. Yang et al. found that the 
degree of chemotaxis towards amino acid attractants shown by an E. coli, correlates with its 




the NMEC strains in the expression of proteins related to peptide and amino acid transport. 
Transporters for oligo- and dipeptides, as well as single amino acids, are upregulated compared 
to H622 and IHE3034. In addition to transport, several proteins involved in amino acid 
metabolism see higher levels in this strain. It could be speculated that J53 has devoted more 
resources towards importing and catabolizing amino acids than the NMEC strains, while H622 
and IHE3034 have devoted more resources towards chemotactic detection of amino acids. 
A mammalian host environment is limited in available iron, an essential nutrient for bacteria. 
Pathogenic bacteria are often able to sense that they are inside a host, by noticing a period of 
iron starvation [170]. If one considers Figure 15, it becomes clear that iron acquisition proteins 
have strong presences in H622 and IHE3034. Noteworthy, ChuA is not detected in J53, nor is 
the gene fragment from the chuA gene (Figure 1). 
Effectiveness in acquiring iron is considered a virulence factor, and one often seen in NMEC 
strains [37, 42].  Iron levels are in fact so vital for microorganisms, that one effect of the human 
inflammatory response is to secrete molecules that sequester iron from the plasma, lowering 
the levels available for the pathogen [171]. Interestingly, the IroCN proteins show a strong 
presence, and IroN has been pointed out earlier by Russo et al. as a potential vaccine antigen 
[172]. Several proteins described in this work may have multiple roles, many of which are not 
yet fully elucidated. One of these is the Outer membrane protein OmpW. In addition to being 
postulated as involved in iron uptake and iron-related virulence, experimental evidence suggests 
this protein also confers resistance to phagocytosis [124, 125]. Wu et al. found that high levels 
of OmpW protected E. coli strains from being phagocytosed by mouse macrophages [125]. The 
fact that H622 and IHE3034 express high levels of iron acquisition proteins reflect their 
adaptation as efficient pathogens. Or “efficient pathogens when the opportunity arises”. These 
are very adaptable bacteria, and can be carried in the gut without causing illness.  
While J53 expresses low levels of these proteins, it expresses higher levels of peptide transport 
proteins OppABCF and DppABCDF. It has been postulated that DppABCDF are able to 
function as a heme permease, enabling the bacterium to internalize and use heme iron [129]. 
One protein does differ from the pattern, however; OppD. This protein was only detected in 
one replica in J53 when grown in blood culture, at a log2-normalized LFQ level of 23.6 
(Supplementary materials Table S1). In order to be regarded as detected in a strain in this work, 
a protein has had to be detected in at least two replicas in a strain. OppD and OppF are the two 
ATP-binding and -hydrolysis proteins in the opp operon [128]. The cause for OppD not being 




All three strains express proteins for iron acquisition, though they differ in which proteins they 
favour. It is also worth noting that the iron acquisition proteins favoured by J53 are fewer in 
number, but are expressed at higher levels than those favoured by the NMEC strains. It would 
seem that the three strains employ different tactics in order to acquire iron in an iron-limited 
environment.   
Sialic acid is usually not synthesized by bacteria, but can be used by them as a source for carbon, 
nitrogen and energy [173]. The NMEC strains show a high expression of proteins involved in 
both catabolism of sialic acid and synthesis of polysialic acid (Figure 12A, Figure 14). 
Interestingly, the repressor of nan-proteins, NanR, is detected at the same levels across strains, 
despite the general higher level of the proteins it represses in H622 and IHE3034. Synthesis of 
polysialic acid by neu- and kps-genes is responsible for synthesis of the K1 capsule, and these 
proteins are not seen in J53 at all. It is very unlikely it carries the genes for these proteins, as 
they are not found in any databases pertaining derivatives of E. coli K12. The E. coli H622 has 
not been serotyped, but the presence of these proteins makes it highly likely that it has the 
capsular antigen K1.  
The K1 capsule, as mentioned earlier, is a virulence factor that enables the bacterium to 
“camouflage” itself using polysialic acid NeuNAc(α2-8) [45]. This makes it less likely to be 
spotted by the host’s innate immune system. Not only does it help the bacterium avoid 
detection, it is anti-phagocytic, protects the bacterium from surface accumulation of C3b, and 
assists the bacterium in crossing the BBB [45, 46]. A protein that may also play an important 
role in avoiding complement activation and serum killing, is Outer membrane protein OmpA. 
This protein is well-studied, and may have many roles. It has been suggested as functioning as 
an outer membrane porin, and/or as an anchor between the outer membrane and the 
peptidoglycan cell wall [174, 175]. This protein has been demonstrated to protect E. coli K1 
from complement activation, possibly by binding C4bp and stopping the rest of the complement 
cascade [38]. OmpA is found at very similar levels in all strains grown in clinical blood culture, 
with an average log2-normalized LFQ level of 31.4, ± 0.4 (Not explicitly shown, LFQ intensities 
of all proteins can be found in supplementary materials, Table S1). The similar levels of 
detected OmpA indicates that although non-pathogenic and pathogenic E. coli differ in protein 
expression, they also share many traits. As OmpA may have several functions, no conclusions 
can be drawn as to the role it fills in the respective bacteria presented here. 
The drastically higher LFQ intensities of galactitol-degrading gat-proteins in J53 can be seen 




The multidrug efflux pump proteins EmrAB are unrelated to the resistance towards sodium 
azide exhibited by J53. That resistance is thought to be conferred by a mutation of the SecA 
gene [176]. These proteins did not grant J53 resistance towards any of the tested antimicrobials 
(Table 8).  
The stress response proteins IbpAB are not similarly expressed between H622 and IHE3034. 
IbpB is expressed very differently between them, with the highest levels seen in H622. While 
IbpB is not detected in J53 at all, the important factor here, is that the expression is higher in 
both NMEC strains than in J53. Kuczyńska-Wiśnik et al. demonstrated that a lack of IbpAB 
lead to higher levels of extracellular indole, and an inhibition of biofilm formation [135]. This 
is interesting when considering the high levels of TnaA found in J53 (Figure 16B). Perhaps it 
should be seen the other way; TnaA is not only detected at high levels in J53, but at low levels 
in the NMEC strains. As the tryptophanase TnaA increases extracellular indole concentrations, 
it may also inhibit biofilm formation [135]. TnaA could be considered in relation to the 
generally higher level of proteins involved in amino acid metabolism found in J53. None of 
these explanations contradict the other. TnaA may be downregulated in H622 and IHE3034, 
while upregulated in J53.  
Some of the strongly expressed proteins differ between the NMEC strains. This is not 
surprising, and serves as a reminder that despite the close relations and similar protein 
expression, they are two different strains of E. coli. 
 
The challenges of maintaining a bacterial strain in vitro 
It is clear that IHE3034 has changed during its laboratory passage, as it originally had one small 
and one large plasmid, and now it has none [20, 177]. Bacteria losing plasmids during in vitro 
passage is a well-known phenomenon, and can happen due to cell division (segregational loss), 
or when the cost of keeping the plasmid outweighs the benefits conferred to the bacterium [178].  
Moriel et.al. claims in the materials and methods section of their paper that IHE3034 “is more 
virulent than the ancestor strain in the sepsis mouse model” [20]. It is uncommon to hear of a 
bacterial strain that becomes more virulent during laboratory passage, unless it is cultured 
through an animal model. Usually, the opposite is true; maintaining strong virulence does not 
benefit the bacterium if there is no pressure to do so. Moriel et al. do not describe the basis for 
their comparison – there are no references to an experiment having been done with the parent 
strain. Their assessment of it being more virulent therefore seems unfounded, and cannot be 




While the NMEC strains clearly are closely related and share several genetic and proteomic 
traits, it is important to note the large temporal distance between their isolations. While 
IHE3034 was isolated in Finland in 1976, H622 was isolated at Haukeland University Hospital 
in 2012 [177] (Nothing is yet published on H622). This entails that IHE3034 has been 
maintained in laboratory conditions for around 40 years, while H622 has been kept locally since 
its isolation. Keeping a bacterial strain unchanged for 40 years is – to put it lightly – a 
demanding task. Commercial vendors and organisations such as the ATCC follow strict rules 
and guidelines to keep their cultures close to the original. They use a seed lot system where 
several cultures of the same strain are frozen at passage zero, and can be thawed when new 
cultures are needed [179, 180]. Each seed can give rise to several “working” cultures, thus 
keeping the original strain from mutating and changing, as can often happen through long-term 
passage in vitro.  
 
5.4.4 – Culturing conditions have an impact on protein expression 
Included in the MaxQuant data analysis were raw files from an earlier experiment in the 
research group. Here, IHE3034 and J53 had been cultured on blood agar before being subjected 
to the same digestion and LC-MS/MS analysis as described. 
The scatter plot comparing the strains under different growth conditions indicate that the 
changes in protein expression between cultivation in blood agar and blood culture is very 
similar between the strains (Figure 18). They have a Pearson correlation coefficient of 0.739 
and 0.725, respectively. The number of proteins that vary is very similar, supporting the notion 
that the strains respond to the changes between clinical blood culture and blood agar similarly 
(Table S6 and Table S7 in supplementary materials). The proteins that change in expression 
between conditions are directly linked to the differences in media. These include proteins 
involved in carbohydrate metabolism, degradation of fatty acids, and proteins triggered by 
osmotic stress. This reflects the changes in available nutrients, as well as the osmolarity of the 
medium. The response is the same as was seen when Pettersen et.al. compared UPEC strain 
536 grown in clinical blood culture and on blood agar [59]. Higher expression levels of systems 
responsible for the uptake of nutrients can be seen in connection with blood agar being a 
nutrient-rich medium. Reflecting the findings in this work, Pettersen et al. also detected a 
distinct upregulation of AceAB, AcnAB, Acs, Icd, SdhABCD, and SucABCD, some of which 
they contributed to glyoxylate degradation systems being induced by growth on acetate [59]. 




clinical blood culture. This suggests that they are both capable of sensing when they are grown 
in liquid media, and adapting to this. The results confirm an important aspect of E. coli, that it 
is a very versatile bacterium, able to adapt to changing environments. 
Concluding remarks 
The main differences between E. coli strains H622, IHE3034 and J53 reflect adaptations of 
pathogenic and non-pathogenic bacteria. While the commensal K12 derivative J53 directs 
energy into nutrient scavenging, the pathogenic NMEC strains H622 and IHE3034 express 
higher levels of virulence factors such as proteins responsible for motility, biofilm formation, 
iron acquisition, and capsule synthesis. The NMEC strains show a greater similarity in genetic 
makeup and evolutionary relations with each other than either does with J53. 
When grown on blood agar, the strains demonstrated many of the changes that have been 
detected in earlier works, most of which pertain to the availability of nutrients in blood agar 
compared to clinical blood culture. 
We have compared the proteomic expressions of H622, IHE3034 and J53 successfully using 
mass spectrometry. We have also determined the evolutionary relations between the strains, 
and characterised H622 genetically and phenotypically.  
Future perspectives 
This work has focused mainly on comparing the proteomic expression of H622 and IHE3034 
to that of J53. The results presented here shed light on some of the processes that differentiate 
pathogenic E. coli strains from commensal ones.  
Mass spectrometric analyses yield massive amounts of data. Future and more detailed analyses 
of the raw data acquired here can be used to expand our knowledge about the protein expression 
of the strains presented. The raw files have been deposited to the ProteomeXchange Consortium 
with the dataset identifier PXD005779, and will be made accessible upon publication. The data 
may also be employed to further the search for vaccine antigens found in pathogenic E. coli. 
Valuable for this endeavour, mass spectrometry has the strength of being able to detect outer 
membrane proteins. The two NMEC strains H622 and IHE3034 should be more thoroughly 
compared to detect differences between the strains, and to create a detailed and inclusive 
pathotype. The mass spectrometry data can be used in general studies of E. coli and comparison 
of these strains to other pathotypes such as ETEC, UPEC, and SEPEC. The sequenced genomes 




An interesting experiment that could create a basis for comparison would be to grow the same 
strains in a liquid medium such as Luria Bertani broth, in order to compare E. coli grown in 
liquid non-human medium to those grown in clinical blood culture. This way, one can assess 
whether or not the observed changes are caused by liquid culture conditions, or other factors 
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